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Abstract 
 
In the adult mammalian brain, new neurons can be generated (adult neurogenesis) due 
to the presence of neural stem cells (NSC). Adult neurogenesis can be affected by 
several factors and is particularly altered in pathological conditions, which can increase 
NSC proliferation, migration and differentiation into neurons. However, neurogenesis 
after brain injury is not efficient due to low survival of new neurons. Brain insults trigger 
neuroinflammation with activation of microglia, which release several molecules, such 
as nitric oxide (NO). NO from inflammatory origin enhances adult neurogenesis through 
ERK/MAPK pathway signaling, but the exact mechanism is unknown. NO can directly 
modify protein function through S-nitrosylation, the addition of S-nitrosothiol to a cysteine 
thiol group. In this work, we aimed to validate new putative targets of S-nitrosylation by 
NO in NSC that are involved in the ERK/MAPK pathway, which were recently identified 
by our group. Here, we describe the S-nitrosylation of these new targets in conditions of 
increased post-injury neurogenesis mediated by NO and study in more detail 
phosphatidylethanolamine binding protein 1 (PEBP-1). PEBP-1 inhibits the ERK/MAPK 
pathway by binding to c-Raf and is the most promising target for neurogenesis. We show 
that S-nitrosylation of cysteine 133 of PEBP-1 is necessary for ERK phosphorylation 
induced by NO in NSC, which can be a mechanism involved in the release of PEBP-1 
inhibitory function in the ERK/MAPK pathway. Moreover, in a model of post-injury 
neurogenesis we show that 14-3-3, 14-3-3 , hnRNP K and PEBP-1 are transiently S-
nitrosylated following seizures, according to their role in the ERK/MAPK pathway, 
preceding the onset of proliferation of NSC. Overall, our data shows that these proteins 
may be important for regulation of post-injury neurogenesis and suggests that they could 
be good candidates for regulation, in order to enhance NSC proliferation and neuronal 
replacement efficiency following brain injury. 
 
Keywords: Adult neurogenesis, nitric oxide, S-nitrosylation, neural stem cells, brain 
injury, hippocampus 
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Resumo 
 
No cérebro adulto dos mamíferos, são produzidos novos neurónios (neurogénese) 
devido à presença de células estaminais neurais (NSC). A neurogénese pode ser 
afectada por diversos factores e está particularmente alterada em condições 
patológicas, o que pode aumentar a proliferação de NSC, migração e diferenciação em 
neurónios. No entanto, a neurogénese após lesão cerebral não é eficiente devido à 
baixa sobrevivência dos novos neurónios. Diversas lesões cerebrais desencadeiam 
neuroinflamação com activação da microglia, que liberta diversas moléculas, tal como o 
óxido nítrico (NO). O NO de origem inflamatória melhora a neurogénese adulta através 
de sinalização pela via da ERK/MAPK, mas o mecanismo exacto é desconhecido. O NO 
pode modificar directamente a função de proteínas através de S-nitrosilação, pela 
adição de S-nitrosotiol ao grupo tiol de uma cisteína. Neste trabalho, tivemos como 
objectivo validar novos possíveis alvos de S-nitrosilação pelo NO envolvidos na via da 
ERK/MAPK em NSC, e que foram recentemente identificados pelo nosso grupo. Aqui, 
descrevemos a S-nitrosilação destes novos alvos em condições de neurogénese pós-
lesão aumentada pelo NO e estudamos em mais detalhe a proteína de ligação a 
fosfatidiletanolamina 1 (PEBP-1). A PEBP-1 inibe a via da ERK/MAPK ao ligar-se à c-
Raf e é o alvo mais promissor para a neurogénese. Mostramos que a S-nitrosilação da 
cisteína 133 da PEBP-1 é necessária para a fosforilação da ERK induzida pelo NO em 
NSC, o que pode ser um mecanismo envolvido em ultrapassar a função inibitória da 
PEBP-1 na via da ERK/MAPK. Além disso, mostramos que num modelo de 
neurogénese pós-lesão as proteínas 14-3-3, 14-3-3 , hnRNP K e PEBP-1 estão S-
nitrosiladas de forma transiente após convulsões, de acordo com a sua função na via 
da ERK/MAPK, e precedendo o início da proliferação de NSC. No geral, este trabalho 
mostra que estas proteínas poderão ser importantes para a regulação da neurogénese 
pós-lesão e sugere que possam ser boas candidatas para serem reguladas, de forma a 
melhorar a proliferação de NSC e a eficiência da substituição neuronal após lesão 
cerebral. 
 
Palavras chave: Neurogénese, óxido nítrico, S-nitrosilação, células estaminais neurais, 
lesão cerebral, hipocampo 
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1.1. Adult neurogenesis 
The formation of new neurons (neurogenesis) in the brain was thought for a long time to 
only occur during embryogenesis. Ramón y Cajal in 1894 described for the first time the 
complex structure of brain neuronal networks and speculated that they were fixed and 
irreplaceable. This led to the idea that, contrary to other tissues, there was no way to 
replace neurons that are lost in the adult brain due to injury or aging. However, in 1965, 
Altman and Das observed proliferation of cells in rat hippocampus (Altman & Das 1965), 
contradicting the previous established paradigm. Since then, adult neurogenesis has 
been an intense subject of investigation and, nowadays, it is well established that there 
is formation of new neurons during the adult life of mammals, both in physiological and 
pathological conditions.  
Neurogenesis in the adult occurs to maintain brain structure and plasticity, and can 
increase in response to harmful stimuli. It is present in different animal species, ranging 
from invertebrates (Tanaka & Reddien 2011, Koizumi & Bode 1991, Fernandez-
Hernandez et al. 2013) to non-mammalian (Chapouton et al. 2007, Alunni & Bally-Cuif 
2016) and mammalian (Brus et al. 2013) vertebrates. With the discovery of adult 
neurogenesis in humans (Eriksson et al. 1998) emerged the possibility of brain 
regeneration taking advantage of neural stem cells (NSC) for transplantation or 
enhancement of endogenous neurogenesis, in situations detrimental to normal brain 
functioning. Neurogenesis is a complex process, comprising proliferation, migration, 
differentiation and survival of the newly formed neurons, with functional integration in the 
existing neuronal circuits. Despite its importance, neurogenesis in mammals is restricted 
to certain areas of the adult brain, due to the presence of pools of NSC in specific regions. 
In the subventricular zone (SVZ) and in the hippocampus, new neurons are generated 
during adulthood. Neurogenesis in the SVZ is important for replacement of neurons of 
the olfactory bulb (OB), which is crucial for odor discrimination and processing of sensory 
information. Unlike several species, in humans there are few new OB neurons originating 
from neurogenesis in the SVZ, and OB neurogenesis seems to have little relevance 
(Bergmann et al. 2012). Interestingly, humans present more new neurons in the adult 
striatum than other mammals, but it is still elusive if these new neurons originate in the 
SVZ (Ernst et al. 2014). Hippocampal neurogenesis is critical for learning, memory and 
cognition and is conserved across mammals, including in humans (Gould et al. 1999, 
Spalding et al. 2013).  
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1.1.1. Neurogenic niches 
In the adult mammalian brain, the SVZ that lines the lateral walls of the lateral ventricles 
(Fig. 1.1A) and the subgranular zone (SGZ) of the dentate gyrus (DG) of the 
hippocampus (Fig. 1.1D) are the main regions that contain NSC. These cells have the 
ability of self-renewal, slowly proliferating by either symmetric or asymmetric divisions 
(Morrison & Kimble 2006), and are multipotent, having the ability to originate neurons, 
astrocytes and oligodendrocytes (Lois & Alvarez-Buylla 1993). 
In the SVZ, ependymal cells line the ventricles and separate the SVZ from the 
cerebrospinal fluid (Fig. 1.1B). NSC can contact the cerebrospinal fluid extending an 
apical process between rosettes of ciliated ependymal cells (Lim & Alvarez-Buylla 2016). 
Blood vessels also provide the necessary nutritional support to NSC, as well as access 
to regulatory and signaling molecules (Mercier et al. 2002). NSC (B cells) give rise to 
transient amplifying progenitors (C cells), rapidly proliferative cells with limited self-
renewal capacity, which in turn originate neuroblasts (A cells, immature neurons) 
(Doetsch et al. 1997). Neuroblasts migrate long distances in chains along the rostral 
migratory stream (RMS) towards the OB (Lois & Alvarez-Buylla 1994, Lois et al. 1996), 
where they differentiate into granular and periglomerular neurons and integrate in the 
existing neuronal circuits as inhibitory interneurons (Alvarez-Buylla & Garcia-Verdugo 
2002). Additional paths of migration have been described in mouse brain, with 
neuroblasts derived from the SVZ migrating towards forebrain regions such as cortex, 
striatum, and nucleus accumbens (Inta et al. 2008). In humans, neurogenesis in the OB 
is limited and the presence of a RMS is controversial (Curtis et al. 2007, Sanai et al. 
2011), but neuroblasts derived from the SVZ may migrate to striatum (Ernst et al. 2014).   
The SGZ (Fig. 1.1E), located between the hilus and the granule cell layer of the 
hippocampus, is also a vascularized region (Palmer et al. 2000). There, radial glia-like 
cells (type-1 cells) proliferate and originate transient amplifying progenitors (type-2a and 
2b cells) (Kempermann et al. 2004), which proliferate rapidly and give rise to neuroblasts 
(type-3 cells) (Doetsch 2003). Neuroblasts migrate short distances towards the granule 
cell layer of the DG and differentiate into functional granular neurons that extend their 
axons into the CA3 region (van Praag et al. 2002). 
In the neurogenic niches, NSC are maintained in a stem state due to the presence of 
several factors and interaction with different cells. NSC transplanted to different regions 
of the brain differentiate into neurons or glia depending on the transplanted site, and 
regardless of the origin of NSC (Shihabuddin et al. 2000, Seidenfaden et al. 2006). 
Therefore, environmental cues are necessary for the maintenance of NSC properties 
and fate commitment. The different types of cells present in the niches can be 
distinguished and identified according to specific cell markers (Fig. 1.1C,F). NSC are 
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from a glial lineage (Kriegstein & Alvarez-Buylla 2009) and therefore express glial 
fibrillary acidic protein, which is absent in neural progenitor cells that in turn express sex 
determining region Y-box 2 (Sox2) and nestin (both also present in NSC) (Filippov et al. 
2003, Zhang & Jiao 2015). Upon commitment towards a neuronal fate, neuroblasts 
express doublecortin, but not nestin (Kronenberg et al. 2003). Fully mature neurons can 
be identified by expression of Neuronal nuclei (NeuN) and -III-tubulin. Neurogenesis 
and its regulation can be studied using cultures of NSC. They can be isolated and 
cultured in vitro both as an adherent monolayer or as floating aggregates 
(neurospheres), being maintained as multipotent by epidermal growth factor (EGF) 
and/or basic fibroblast growth factor (bFGF) (Weiss et al. 1996, Kuhn et al. 1997). 
 
 
Figure 1.1 - Neurogenic niches in the adult mammalian brain. Representation of the 
neurogenic niches of the SVZ (A-C) and the SGZ of the DG (D-F). The SVZ lines the lateral wall 
of the lateral ventricles (A), where NSC (B cells) contact the cerebrospinal fluid through ciliated 
ependymal cells (E) and give rise to highly proliferative transient amplifying progenitors (A cells), 
which in turn originate neuroblasts (C cells) (B). In the SGZ of the DG of the hippocampus (D), 
radial glia-like cells (type-1) give rise to transient amplifying progenitors (type-2a and 2b), which 
originate neuroblasts (type-3) that migrate and differentiate into DG neurons (E). The different 
types of cells can be distinguished by expression of different markers (C,F). LV, lateral ventricle; 
BV, blood vessel; GFAP, glial fibrillary acidic protein; Sox2, sex determining region Y-box 2; DCX, 
doublecortin; NeuN, Neuronal nuclei. 
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1.1.2. Regulation of neurogenesis 
Neurogenesis is a highly-regulated process, being affected by several components of 
the neurogenic niches, such as intrinsic factors of NSC, immune cells, extracellular 
matrix components, vascular system and signaling pathways (Christie & Turnley 2012). 
EGF promotes NSC proliferation in the SVZ and glial differentiation in both the SVZ and 
SGZ (Kuhn et al. 1997). bFGF increases NSC proliferation and neuronal differentiation 
in the SVZ (Kuhn et al. 1997), and is necessary for neurogenesis in the SGZ (Kang & 
Hebert 2015). Insulin-like growth factor 1 (IGF-1) promotes migration of neuroblasts to 
the OB and neuronal differentiation (McCurdy et al. 2005, Hurtado-Chong et al. 2009) 
and, in the SGZ, it enhances NSC proliferation and increases cell survival (Aberg et al. 
2000, Lichtenwalner et al. 2006). Notch signaling is important for the self-renewal 
capacity and maintenance of NSC pool in the SVZ (Imayoshi et al. 2010). In the SGZ, 
Notch is necessary for neurogenesis, affecting proliferation, differentiation and survival 
of new neurons (Breunig et al. 2007). Sonic hedgehog signaling is necessary for 
maintenance of NSC pool in both the SVZ and SGZ (Machold et al. 2003) and migration 
of neuroblasts in the SVZ (Balordi & Fishell 2007). Canonical Wingless-type (Wnt) 
signaling in the SVZ increases NSC proliferation (Adachi et al. 2007) and post-injury 
neurogenesis (Shruster et al. 2012), while in the SGZ it is important for maintenance of 
NSC pool (Wexler et al. 2009) and for increase in neurogenesis (Lie et al. 2005). Non-
canonical Wnt signaling influences maturation of new neurons in the OB (Pino et al. 
2011) and DG (Varela-Nallar et al. 2010). Bone morphogenetic protein signaling in the 
SVZ decreases neurogenesis by increasing glial differentiation, which is prevented by 
Noggin (Lim et al. 2000). Nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF-B) signaling is necessary for differentiation of new hippocampal neurons (Rolls et 
al. 2007).  
Factors outside the niches also regulate neurogenesis. Hormonal differences between 
males and females affect neurogenesis. In female rats, estrogen during proestrous 
increases proliferation of NSC and enhances neurogenesis in the hippocampus 
(Tanapat et al. 1999). Pregnancy hormones also increase proliferation of NSC, in mouse 
and rat SVZ (Shingo et al. 2003, Furuta & Bridges 2005). Testosterone affects 
neurogenesis, so male castration of certain mouse strains leads to increase in 
proliferating cells in the SVZ (Tatar et al. 2013).  
Physical exercise, particularly running, enhances hippocampal neurogenesis (van Praag 
et al. 1999b, Naylor et al. 2008, Bednarczyk et al. 2011) and improves cognition (van 
Praag et al. 1999a). This effect is mediated by increase in brain-derived neurotrophic 
factor (BDNF) (Farmer et al. 2004) and presence of serotonin (Klempin et al. 2013). 
Exercise induces angiogenesis (Black et al. 1990, Swain et al. 2003), releasing factors 
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that also increase neurogenesis, such as vascular endothelial growth factor (VEGF) (Jin 
et al. 2002). 
Environmental enrichment is the improvement in housing conditions of laboratory 
animals, to increase cognitive stimulation (Baumans & Van Loo 2013). Some of the 
strategies used are bigger cages, new objects and social interaction by contacting with 
other animals. Environmental enrichment leads to increased survival of mice and rat 
hippocampal newborn granular neurons (Kempermann et al. 1997, Kempermann et al. 
2002, Segovia et al. 2006). Animals with more neurogenesis also display better 
performance in cognitive tests that evaluate spatial memory, highlighting the association 
between the amount of new neurons and ability to learn (Sisti et al. 2007). This cognitive 
stimulation in adulthood helps prevent a decline in neurogenesis with aging, by 
maintaining the pool of NSC (reviewed in Kempermann 2008). Environmental 
enrichment also increases the number of neuronal branches and dendritic spines 
(Rampon et al. 2000), which improves synaptic activity. These effects are mediated by 
an increase in transcription factors, such as cyclic adenosine monophosphate (cAMP) 
response element-binding (CREB) (Williams et al. 2001), in proteins involved in 
synaptogenesis (Frick & Fernandez 2003, Nithianantharajah et al. 2004) and in 
neurotrophic factors, such as BDNF (Zhang et al. 2016). Running wheels are usually a 
part of environmental enrichment, so some studies evaluated the contribution of exercise 
for the effect in neurogenesis observed with environmental enrichment, concluding that 
increase in BDNF and proliferation of hippocampal NSC results mainly from physical 
exercise (Kobilo et al. 2011, Bechara & Kelly 2013). Therefore, physical exercise is 
responsible for increasing the proliferation of NSC, and environmental enrichment is 
responsible for increasing the survival of new neurons (reviewed in Olson et al. 2006). 
Environmental enrichment is able to reduce stress in mice (Olsson et al. 1994, 
Sztainberg et al. 2010). Chronic stress impairs hippocampal neurogenesis, due to 
increase in glucocorticoids that inhibit the proliferation of NSC and/or differentiation into 
neurons (Ridder et al. 2005, Kronenberg et al. 2009, Hodes et al. 2012, Anacker et al. 
2013). High levels of glucocorticoids also lead to decreased levels of BDNF (Smith et al. 
1995, Gourley et al. 2009). Astrocytes are important for neurogenesis (Song et al. 2002, 
Sultan et al. 2015) and may have a major role in modulating neurogenesis in conditions 
of stress (reviewed in Luarte et al. 2017).  
Aging impairs all steps of neurogenesis. In aged brains, NSC enter a more quiescent 
state, which leads to a decrease in proliferating NSC both in the SVZ and SGZ (Bouab 
et al. 2011, Lugert et al. 2010). Fate specification is also altered with aging, resulting in 
increased glial differentiation and decreased neuronal differentiation (Encinas et al. 
2011). The environment of neurogenic niches is a main contributor to the differences 
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observed in neurogenesis of young and aged mice (Villeda et al. 2011, Katsimpardi et 
al. 2014). Alterations in Wnt signaling (Piccin et al. 2014), and in the factors IGF-1, bFGF, 
VEGF (Shetty et al. 2005) and EGF (Enwere et al. 2004) have been described to play a 
role in decreasing neurogenesis in the aged brain. In humans, neurogenesis in the SVZ 
declines earlier (Sanai et al. 2011) than hippocampal neurogenesis (Spalding et al. 
2013).  
 
1.1.3. Neurogenesis in pathological conditions 
Adult neurogenesis is affected in pathological conditions, such as stroke, traumatic brain 
injury (TBI), epilepsy and neurodegenerative diseases. In animal models of both 
transient global brain ischemia and focal brain ischemia, neurogenesis is increased in 
the SVZ (Tonchev et al. 2005, Jin et al. 2001) and SGZ (Kee et al. 2001, Arvidsson et 
al. 2001). Proliferation of NSC is increased following ischemic stroke (Takagi et al. 1999), 
and cultured NSC derived from ischemic brain show more proliferative capacity and 
differentiation into neurons (Deierborg et al. 2010). Moreover, neuroblasts derived from 
proliferation of NSC in the SVZ switch their migration route from the RMS towards the 
site of lesion in the striatum (Arvidsson et al. 2002, Zhang et al. 2004). There is also 
increased angiogenesis in the SVZ (Zhang et al. 2014) and in the dorsomedial striatum 
near the SVZ, so the new blood vessels provide a scaffold for migration of new 
neuroblasts (Thored et al. 2007), like in the RMS in physiological conditions. Factors of 
the neurogenic niches, such as bFGF (Lin et al. 1997) and IGF-1 (Yan et al. 2006) 
increase in the ischemic cortex following stroke, and their absence prevents 
enhancement of neurogenesis (Yoshimura et al. 2001, Yan et al. 2006). Despite the 
enhancement of neurogenesis, in ischemic stroke conditions the new neurons have low 
long-term survival (Arvidsson et al. 2002, Thored et al. 2006), and aberrant morphologies 
that lead to maladaptive integration in the existing circuits and memory impairment (Niv 
et al. 2012, Woitke et al. 2017).  
In animal models of TBI, there is increase in NSC proliferation in the SVZ and SGZ 
(Chirumamilla et al. 2002, Gao et al. 2009). Moreover, there is enhancement of neuronal 
differentiation in some models (Dash et al. 2001, Rice et al. 2003, Villasana et al. 2014), 
whereas in others there is only increase in glial differentiation (Bye et al. 2011, Gao & 
Chen 2013), which can be modulated by age (Sun et al. 2005). VEGF mediates 
increased hippocampal neurogenesis following TBI, by promoting survival of the new 
granule neurons (Lee & Agoston 2010). In the SVZ, Eph receptor B3, which is necessary 
for negative regulation of cell proliferation and survival by EphrinB3 (Ricard et al. 2006), 
is transiently reduced following TBI and allows proliferation and survival of NSC (Theus 
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et al. 2010). Other factors involved in the increase in neurogenesis and survival of new 
neurons following TBI are bFGF (Sun et al. 2009b), EGF (Sun et al. 2010), IGF-1 
(Carlson et al. 2014) and BDNF (Gao & Chen 2009). 
Epilepsy is characterized by spontaneous recurrent seizures, which can disrupt adult 
neurogenesis. Several days following seizures, NSC proliferation is increased both in 
the SVZ (Parent et al. 2002) and SGZ (Gray & Sundstrom 1998), returning to 
physiological levels after a few weeks (Parent et al. 1997, Bonde et al. 2006). Most 
newborn cells differentiate into granule neurons (Jessberger et al. 2007). Notch (Sibbe 
et al. 2012), Sonic hedgehog (Banerjee et al. 2005) and Wnt (Jang et al. 2013) signaling 
pathways are involved in increasing neurogenesis after seizures. Expression of factors 
such as BDNF (Isackson et al. 1991) and VEGF (Newton et al. 2003) are altered after 
seizures and may also affect proliferation of NSC. Many hippocampal granule neurons 
born after seizures present abnormal morphologies, presenting hilar basal dendrites 
(Ribak et al. 2000, Dashtipour et al. 2003, Shapiro et al. 2005) and mossy fiber sprouting 
(Kron et al. 2010). Changes in the glial scaffold may be involved in this process (Shapiro 
et al. 2005). Nevertheless, functional integration occurs, with establishment of recurrent 
excitatory networks, of the new abnormal hippocampal granule neurons (Jessberger et 
al. 2007), and seems to be accelerated by seizures (Overstreet-Wadiche et al. 2006). 
Migration is also altered after seizures. In the SVZ, some neuroblasts leave the RMS 
towards non-olfactory forebrain regions, where they are not able to survive (Parent et al. 
2002). In the DG, some granule cells migrate ectopically to the hilus and the border 
hilus/CA3 and integrate the existing circuits (Parent et al. 1997). However, this 
integration is abnormal and the new ectopic granule neurons burst in synchrony with 
CA3 pyramidal cells (Scharfman et al. 2000). Loss of reelin signaling (Gong et al. 2007) 
and excessive mechanistic target of rapamycin (mTOR) signaling (Pun et al. 2012) may 
be involved in this abnormal migratory behavior. Despite the initial increase in 
neurogenesis, the potential for neurogenesis is decreased several weeks following 
seizures (Hattiangady et al. 2004, Kralic et al. 2005), due to a shift to symmetrical 
divisions, differentiation into reactive astrocytes and depletion of NSC pool (Sierra et al. 
2015).  
In neurodegenerative diseases such as Alzheimer’s disease, Huntington’s disease and 
Parkinson’s disease neurogenesis is also altered. Studies with animal models of 
Alzheimer’s disease show contradictory effects on neurogenesis, due to a large 
variability of factors between studied models. A single mutation of amyloid precursor 
protein transgene results in decreased neurogenesis (Donovan et al. 2006), while double 
and triple mutations lead to increased proliferation and survival of new neurons 
(Haughey et al. 2002, Mirochnic et al. 2009). A triple transgenic mouse model, containing 
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mutation of amyloid precursor protein, presenilin1 and tau genes, also results in impaired 
neurogenesis, associated with presence of β-amyloid plaques (Rodriguez et al. 2008). 
Imbalance between hippocampal GABAergic and glutamatergic neurotransmission 
caused by β-amyloid leads to decrease in neurogenesis (Sun et al. 2009a); and 
apolipoprotein E4, a risk factor for developing Alzheimer’s disease, also has a 
detrimental effect in neurogenesis (Li et al. 2009). In animal models of Huntington’s 
disease, NSC proliferation in the SGZ is decreased (Lazic et al. 2004, Gil et al. 2005), 
and there are less neuroblasts and immature neurons (Fedele et al. 2011). Quiescence 
of NSC pool is increased, CREB signaling is decreased and transforming growth factor-
β signaling seems to be involved in modulating neurogenesis (Kandasamy et al. 2010). 
In the SVZ, proliferation of NSC is maintained, but there are less new OB neurons 
(Phillips et al. 2005, Kohl et al. 2010). Local environment seems to be critical for survival 
of new neurons in the striatum, with contribution of BDNF and Noggin (Cho et al. 2007). 
In animal models of Parkinson’s disease, neurogenesis is decreased in the SVZ and DG 
due to presence of -synuclein. NSC proliferation is impaired in some models (Crews et 
al. 2008, Kohl et al. 2012), while in others there is decrease in survival and integration 
of new neurons (Winner et al. 2004, Nuber et al. 2008, Winner et al. 2012). Alterations 
in CREB (Winner et al. 2012), BDNF and glial cell-derived neurotrophic factor (Kohl et 
al. 2012) may contribute to the impairment of neurogenesis observed in Parkinson’s 
disease. 
 
1.1.3.1. Neuroinflammation 
A common factor in brain pathological conditions is neuroinflammation. Inflammation in 
the brain is characterized by activation of microglia, the main immune cells of the brain, 
release of inflammatory cytokines and disruption of the blood brain barrier, further 
exacerbating the inflammatory response (Russo et al. 2011). In physiological conditions, 
microglia present a ramified morphology and are continuously monitoring the central 
nervous system environment (Nimmerjahn et al. 2005). Upon harmful stimuli, microglia 
become activated and release high amounts of free radicals and cytokines, which can 
be either pro or anti-inflammatory. When activated by lipopolysaccharide, microglia 
release reactive oxygen and nitrogen species, such as nitric oxide (NO), and pro-
inflammatory cytokines, such as interleukin (IL)-1, IL-6 and tumor necrosis factor-, in 
order to protect the organism from foreign pathogens. However, this pro-inflammatory 
activation also affects healthy neurons. Another way of microglial activation involves 
supporting tissue repair and angiogenesis, by releasing anti-inflammatory cytokines, 
such as IL-4, IL-10 and transforming growth factor-. The balance between these two 
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types of activation is critical for the outcome of the inflammatory process and differently 
affects neurogenesis (reviewed in Ekdahl 2012). Acute neuroinflammation appears to be 
detrimental to neurogenesis. Inflammation caused by activation of microglia with 
lipopolysaccharide impairs neurogenesis in rat DG both in normal and injured brain due 
to pro-inflammatory cytokines, such as IL-6 (Ekdahl et al. 2003, Monje et al. 2003). This 
effect results from decreased survival of new neurons, and can be prevented using 
minocycline, which suppresses microglia activation, or indomethacin, a non-steroidal 
inflammatory drug (Ekdahl et al. 2003, Monje et al. 2003). Survival of new neurons in the 
OB is also impaired by microglial activation, and can be rescued using minocycline 
(Lazarini et al. 2012). In a model of stroke, inflammation alters proliferation of NSC from 
the SVZ and survival of new neurons, which can be prevented by treatment with 
indomethacin (Hoehn et al. 2005). On the other hand, activation of microglia by low levels 
of interferon- stimulates differentiation of NSC into neurons (Butovsky et al. 2006). 
Inflammation can also be important for functional integration of new neurons in the 
hippocampus (Jakubs et al. 2008). 
The presence of neuroinflammation in pathological conditions that increase 
neurogenesis may also decrease the survival of new neurons and lead to low efficiency 
of neuronal replacement. It is necessary to understand how cells in different stages of 
neuronal formation/differentiation are affected by inflammatory factors. Strategies to 
overcome this problem are needed, in order to enhance endogenous neurogenesis for 
brain repair. Enhancing the proliferation of NSC, the amount of potential new neurons 
that can survive and functionally integrate in the neuronal circuits increases. Of the 
molecules released by microglia during inflammation, NO has emerged as an important 
regulator of neurogenesis, so its role during this process deserves further investigation. 
 
1.2. Nitric oxide 
1.2.1. Biology of NO 
NO is a free radical that is synthesized by the enzyme nitric oxide synthase (NOS) from 
the conversion of L-arginine into L-citrulline (Fig. 1.2). There are three isoforms of NOS. 
Neuronal NOS (nNOS), mainly present in neurons, and endothelial NOS (eNOS), mainly 
present in endothelial cells, are constitutively expressed and are regulated by calcium 
levels and binding of calmodulin (Alderton et al. 2001). In the brain, inducible NOS 
(iNOS) expression in microglia and astrocytes is triggered by insults to the central 
nervous system and its regulation is independent of calcium-calmodulin, being active 
once expressed (Alderton et al. 2001). nNOS and eNOS release low levels of NO 
(picomolar to nanomolar range), while iNOS releases higher amounts of NO (micromolar 
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range). Levels of NO released and the kinetics of NO synthesis and consumption in vivo 
and in vitro are critical to the outcome of the biological response induced by NO (Hall & 
Garthwaite 2009).  
The use of NO donors, carriers of NO that release it over time, is a common strategy to 
induce NO release in in vitro studies. In this work, three NO donors were used to release 
NO. Diazeniumdiolates (NONOates) spontaneously decompose in solution, at 
physiological temperature and pH (Morley & Keefer 1993). There are several NONOates 
available, with different half-lives. Diethylamine NONOate (DEA/NO) has a short half-life 
of 2 min at 37C, while the half-life of DETA NONOate (NOC-18) is 20 h at 37C 
(Fitzhugh & Keefer 2000). S-nitrosothiols, such as S-nitrosocysteine (CysNO), contain a 
single chemical bond between a thiol group (R-SH) and the NO moiety (Zhang & Hogg 
2005). They release NO under certain biological conditions, or directly transfer the 
nitroso group (R-NO) to other thiol groups (transnitrosylation) (Singh et al. 1996). In 
aqueous solutions, CysNO has a half-life shorter than 2 min, at 37C (Mathews & Kerr 
1993).  
NO is a gaseous molecule with a short half-life (0.64 s in rat cortex) and is highly diffusible 
(diffusion coefficient in rat cortex is 2.2×10−5 cm2/s) (Santos et al. 2011), being able to 
rapidly reach several biological targets at certain limited range. Due to its high reactivity, 
NO lacks a specific molecular target and interacts with several molecules. So, it is 
important for many different processes in the organism, such as vasodilation and smooth 
muscle relaxation, synaptic plasticity, inflammation and apoptosis, as well as 
neurogenesis. The effects of NO are produced through different signaling mechanisms, 
as described next. 
 
 
 
Figure 1.2 - NO is synthesized by NOS enzymes and acts in several pathways. NO is 
synthesized from L-arginine and oxygen by calcium/calmodulin (CaM)-dependent (nNOS and 
eNOS) and calcium-independent (iNOS) isoforms of NOS. It is important for several cellular 
processes and acts by different signaling mechanisms. 
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1.2.2. NO signaling 
1.2.2.1. Classical NO signaling 
Guanylyl cyclases are enzymes that synthesize cyclic guanosine monophosphate 
(cGMP) and exist in two forms: membrane-bound and soluble. Membrane-bound 
guanylyl cyclases are plasma membrane receptors that form homodimers and have an 
extracellular ligand binding domain, a short transmembrane region, and an intracellular 
region with the catalytic domain (Potter 2011). Soluble guanylyl cyclase (sGC) is 
homologous to the catalytic domains of the membrane-bound forms of guanylyl cyclase 
and is a receptor of NO (Fig. 1.3). sGC is a heterodimeric enzyme composed by two 
homologous subunits: an α subunit (α1 or α2) and a β subunit (β1) (Friebe & Koesling 
2009). The α2 subunit interacts with many proteins and allows the α2β1 isoform 
localization to the plasma membrane, while the β1 subunit, which contains a ferrous 
(Fe(II)) heme, is essential for the dimerization and catalytic activity of sGC. At nanomolar 
concentrations, NO binds to sGC and promotes the rupture of the His–Fe(II) bond within 
the heme, leading to a conformational change in the His ligand (Russwurm & Koesling 
2004, Rodriguez-Juarez et al. 2007). This increases the conversion of guanosine 
triphosphate into cGMP by sGC. Submicromolar concentrations of cGMP activate 
cGMP-dependent protein kinases (PKGs), homodimeric serine-threonine kinases. This 
interaction leads to a change in the conformation of PKGs and releases autoinhibitory 
contacts. Phosphodiesterases, particularly 5, 6 and 9, stop sGC/cGMP/PKG signaling 
by degrading cGMP (Lugnier 2006). 
 
 
 
Figure 1.3 - Classical NO signaling. NO binds to the heme group of sGC, which produces cGMP 
from conversion of guanosine triphosphate. cGMP activates PKG, and can be degraded by 
phosphodiesterases (PDE).  
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1.2.2.2. Non-classical NO signaling  
NO can produce its effects in a way that is independent of cGMP and that does not 
involve binding to metal centers, by inducing protein post-translational modifications 
(PTM), such as S-nitrosylation, S-glutathionylation or tyrosine nitration (Fig. 1.4). 
 
 
 
Figure 1.4 - Non-classical NO signaling. NO can directly modify protein function by inducing 
PTM, such as S-nitrosylation (A), S-glutathionylation (B) and tyrosine nitration (C). (A, S-
nitrosylation) NO, in the potent oxidant form N2O3 (1, 2), can react with free thiol groups (R-SH) 
of cysteines leading to the formation of a S-nitrosothiol (R-SNO) (3). (B, S-glutathionylation) 
Glutathione (GSH) can react with S-nitrosylated proteins and lead to the formation of a mixed 
disulfide bond with those cysteines (SSG) (1). Alternatively, NO can react with glutathione, 
originating S-nitrosoglutathione (GSNO) that can react with free thiols, and lead to formation of 
the mixed disulfide bond (2). (C, tyrosine nitration) When in high amounts, NO reacts with 
superoxide anion and originates peroxynitrite (ONOO-) (1), which can react with protein 3-position 
tyrosine residues and form 3-nitrotyrosine (Tyr-NO2) (2). 
 
1.2.2.2.1. S-nitrosylation 
S-nitrosylation, also called S-nitrosation (Martinez-Ruiz & Lamas 2004), is a reversible 
PTM in which a nitroso group (R-NO) is covalently attached to a cysteine thiol (R-SH), 
forming a S-nitrosothiol (R-SNO) (Martinez-Ruiz et al. 2011). Formation and breakage 
of S-nitrosylation does not rely completely on enzymes because the specificity of this 
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reaction does not depend on the recognition of a target by an enzyme. Instead, S-
nitrosylation is dependent on the reactivity between a nitrosylating agent and a target. 
There are three crucial regulatory factors for increasing the specificity and selectivity of 
S-nitrosylation for particular proteins and avoid broad reactivity: subcellular 
compartmentalization, site specificity and denitrosylation specificity (Derakhshan et al. 
2007). Subcellular compartmentalization ensures that higher concentrations of the 
nitrosylating agent around selected cysteine residues lead to increased specificity. S-
nitrosylation is considered a short-range signaling mechanism (Martinez-Ruiz et al. 
2013). Since it is not able to directly react with cysteine thiols (unless in a thiyl radical 
form), high concentrations of NO are needed to induce formation of reactive nitrosylating 
species. S-nitrosothiols can be formed by different mechanisms (Guikema et al. 2005), 
such as the reaction of NO and O2 that results in N2O3, a very potent nitrosylating 
species. Site specificity involves the reactivity of individual cysteine residues in certain 
protein microenvironments, being more susceptible to being S-nitrosylated. Accordingly, 
in physiological conditions only certain residues are modified, while very high 
concentrations of nitrosylating agents may be able to modify slower-reacting cysteines. 
Levels of cellular S-nitrosothiols are usually low, which suggests that denitrosylation is a 
highly active mechanism. The rate of denitrosylation is another critical factor for S-
nitrosylation specificity (Benhar et al. 2009). Of the different mechanisms of 
denitrosylation, two are similar to the pathways used to reduce thiols with other oxidative 
PTM. On the one hand, reaction of S-nitrosothiols with glutathione leads to either protein 
glutathionylation or transnitrosylation. On the other hand, thioredoxin can directly act on 
protein S-nitrosothiols (Lillig & Holmgren 2007). 
 
1.2.2.2.2. S-glutathionylation 
S-glutathionylation is the addition of glutathione to a protein by formation of a mixed 
disulfide bridge with a cysteine residue (Klatt & Lamas 2000, Mieyal et al. 2008). S-
glutathionylation is a stable mechanism of redox signaling controlled by several 
enzymatic mechanisms, and is not dependent on NO, but can be induced by NO and 
reactive nitrogen species. So, protein S-glutathionylation can be induced by peroxynitrite 
(Okamoto et al. 2001, Adachi et al. 2004). Moreover, it can result from the reaction of a 
free thiol and a S-nitrosothiol, so that glutathione can react with a cysteine of a S-
nitrosylated protein, or S-nitrosoglutathione can be formed and react with the cysteine 
thiol. S-glutathionylation has been suggested as being a mechanism to protect the cell 
against thiol oxidation to sulfinic or sulfonic acid (Klatt & Lamas 2000).  
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1.2.2.2.3. Tyrosine nitration 
Tyrosine nitration consists of the addition of a nitro group (-NO2) to the phenolic ring of 
tyrosine residues, resulting in the formation of a 3-nitrotyrosine residue (Martinez-Ruiz 
et al. 2011). It is an irreversible modification, thermodynamically stable under 
physiological conditions. Peroxynitrite, which results from the reaction of NO with 
superoxide, is one of the main nitrating agents, though other reactive species have been 
described (Radi 2004, Souza et al. 2008). There is selectivity for increased nitration at 
individual proteins (Souza et al. 1999, Ischiropoulos 2003), but the factors that regulate 
it are still being investigated (Abello et al. 2009).  
 
1.2.3. NO and neurogenesis  
NO has been established as a regulator of adult neurogenesis. Several studies show 
that physiological levels of NO, released by nNOS, decrease neurogenesis both in the 
SVZ and DG. Abolishment of NO release, in nNOS knockout mice and by 
pharmacological inhibition of rat NOS, increases NSC proliferation in the SVZ and in the 
DG (Packer et al. 2003). Selective inhibition of nNOS increases NSC proliferation in the 
SVZ and causes a delay in neuronal differentiation (Moreno-Lopez et al. 2004). The anti-
proliferative effect of NO released by nNOS is also observed in cultures of NSC derived 
from the SVZ (Matarredona et al. 2004). This effect is mediated by inhibition of epidermal 
growth factor receptor (EGFR) and phosphoinositide-3-kinase/Akt pathway (Torroglosa 
et al. 2007), through S-nitrosylation of EGFR (Murillo-Carretero et al. 2009). In the DG 
of nNOS knockout mice or after selective inhibition of nNOS, there is increased NSC 
proliferation and survival of newborn cells (Zhu et al. 2006, Fritzen et al. 2007). 
On the other hand, NO released by iNOS during inflammation seems to promote 
neurogenesis. In a model of stroke, there is an increase in the proliferation of NSC in rat 
DG, which is prevented by inhibition of iNOS, and in iNOS knockout mice (Zhu et al. 
2003). Our group has been extensively studying the role of NO from inflammatory origin 
in neurogenesis. In SVZ-derived NSC treated with concentrations of a NO donor (NOC-
18) within the pathological range (1, 10 and 100 M), NO has a dual role in the 
proliferation of NSC, dependent on its concentration and time of exposure (Carreira et 
al. 2010). Exposure to high levels of NO for a long period of time decreases the 
proliferation of NSC. In mixed cultures of SVZ-derived NSC and microglia, NO released 
by microglia also decreases NSC proliferation, which is prevented abolishing NO release 
by using iNOS-/- microglia (Carreira et al. 2014). This anti-proliferative effect of NO from 
inflammatory origin results from inhibition of the extracellular signal-regulated kinase 
(ERK)/mitogen-activated protein kinase (MAPK) pathway due to nitration of EGFR by 
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peroxynitrite, which prevents EGFR phosphorylation and its consequent activation 
(Carreira et al. 2014). Exposure of SVZ-derived NSC to low levels of NO (10 M) for a 
short period of time increases NSC proliferation in a biphasic manner (Carreira et al. 
2010, Carreira et al. 2013). In an initial stage, the proliferative effect of NO is mediated 
by activation of the ERK/MAPK pathway, while at a later stage the effect is mediated by 
activation of the sGC/cGMP/PKG pathway (Carreira et al. 2010, Carreira et al. 2013). In 
a mouse model of excitotoxic brain lesion, NO from inflammatory origin increases the 
proliferation of NSC in the DG, but impairs the survival of new neurons (Carreira et al. 
2010, Carreira et al. 2015). Our group recently identified S-nitrosylation of p21Ras in 
cysteine 118 as the mechanism by which NO activates the ERK/MAPK pathway and 
increases NSC proliferation, both in cultures of NSC from the SVZ and in the model of 
excitotoxic brain lesion (Santos et al. 2017). This ultimately leads to translocation of 
cyclin-dependent kinase inhibitor p27KIP1 from the nucleus to the cytosol and allows the 
progression of cell cycle (Carreira et al. 2010) (Fig. 1.5).  
 
 
Figure 1.5 - NO increases NSC proliferation through ERK/MAPK pathway signaling. NO 
bypasses the EGFR and S-nitrosylates cysteine 118 of p21Ras, which activates the downstream 
signaling cascade of protein kinases, ultimately leading to translocation of p27KIP1 to cytosol and 
its degradation, allowing cell proliferation to occur.  
 
 
1.2.3.1. Identification of new putative targets of S-nitrosylation by NO in NSC 
The ERK/MAPK pathway is crucial for the proliferative effect of NO, which can regulate 
protein function by S-nitrosylation. Involvement of S-nitrosylation of some proteins in 
neurogenesis has been described (reviewed in Santos et al. 2015). S-nitrosylation of 
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myocyte enhancer factor 2 transcription factors acts as a redox switch to inhibit both 
neurogenesis and neuronal survival (Okamoto et al. 2014). On the contrary, S-
nitrosylation of histone deacetylase 2 in embryonic cortical neurons regulates dendritic 
growth and branching, due to chromatin remodeling and activation of CREB-dependent 
genes involved in neuronal development, promoted by neurotrophic factors (Nott et al. 
2008). Moreover, S-nitrosylation of histone deacetylase 2 also regulates neuronal radial 
migration during cortical development (Nott et al. 2013). 
Due to the low efficiency of post-injury neurogenesis, the identification of new proteins 
that could be targets of S-nitrosylation by NO and increase neurogenesis is of great 
interest. Therefore, our group identified S-nitrosylated proteins in NSC, in the presence 
of NO (Ana I. Santos, Ana S. Lourenço and Inês Araújo, submitted). SVZ-derived NSC 
were treated with a S-nitrosothiol (CysNO), and proteins were separated by 
bidimensional electrophoresis. Using a technique that allows fluorescent labeling of 
oxidized cysteines (fluorescence switch), there were several spots that appeared on the 
gel of NSC treated with CysNO, but not on the control (non-treated NSC). Those spots 
corresponded to oxidized proteins, which were then collected and analyzed by mass 
spectrometry. Several proteins were identified and, after researching their different 
biological functions, the involvement of some in the ERK/MAPK pathway regulation and 
cell proliferation was evident (Fig. 1.6). The ERK/MAPK pathway is involved in several 
cellular processes such as cell proliferation, differentiation, survival and apoptosis (Kolch 
2005). Through binding of extracellular molecules, such as growth factors and 
hormones, to cell surface receptors, signals are transmitted by different effectors, which 
ultimately alters gene expression and affects cellular behavior. Receptor tyrosine 
kinases span the cell membrane and have an extracellular ligand binding domain and 
an intracellular tyrosine kinase domain, existing as inactive monomers. Ligand binding 
induces dimerization and receptor activation by autophosphorylation. This leads to 
activation of the GTPase p21Ras that binds and activates Raf kinase. Raf 
phosphorylates and activates mitogen-activated protein kinase kinase (MEK), which in 
turn phosphorylates and activates ERK. ERK can either interact with other effectors that 
can translocate to the nucleus, or translocate to the nucleus itself. In NSC, ERK/MAPK 
signaling is involved in cell proliferation mainly through binding of EGF and bFGF to their 
receptors (Sutterlin et al. 2013). 
S-nitrosylation of those proteins of interest was assessed, and some were shown to be 
S-nitrosylated: 14-3-3 (particularly 14-3-3 ), proliferating cell antigen (PCNA), 
heterogeneous nuclear ribonucleoprotein K (hnRNP K), elongation factor (EF)-1 and 
phosphatidylethanolamine-binding protein 1 (PEBP-1). 
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14-3-3 proteins are a family of 7 isoforms of adaptor proteins that regulate cell signaling 
pathways and are highly expressed in the brain (Cornell & Toyo-Oka 2017). During 
postnatal formation of the rat brain, 14-3-3 proteins are differentially expressed and have 
a role in neuronal development and synaptogenesis (Umahara et al. 2011). In the adult, 
they are necessary for hippocampal long-term potentiation and associative learning and 
memory (Qiao et al. 2014). 14-3-3 can activate the ERK/MAPK pathway, which is 
involved in the proliferative effect of NO in NSC (Carreira et al. 2010), by interacting with 
c-Raf (Chang & Rubin 1997, Roberts et al. 1997). The isoform 14-3-3  is highly 
expressed in the human hippocampus and is upregulated in temporal lobe epilepsy 
(Schindler et al. 2006). Moreover, 14-3-3  has an important role in neurogenesis and 
neuronal migration (Toyo-oka et al. 2014), and has been described to be S-nitrosylated 
in mesangial cells (Kuncewicz et al. 2003).  
PCNA is necessary for DNA replication and is, therefore, essential for cell proliferation. 
Its regulation by PTM is essential for inducing a different set of cellular functions during 
DNA replication (Choe & Moldovan 2017). In response to EGFR signaling, which is 
involved in NSC proliferation (Gritti et al. 1995), PCNA is phosphorylated and protected 
from degradation (Wang et al. 2006). PCNA can be S-nitrosylated in cysteine 81 (Lam 
et al. 2010), which blocks its interaction with caspase-9 and promotes apoptosis in a 
human neuroblastoma cell line (Yin et al. 2015).  
hnRNP K belongs to a family of proteins that bind RNA and are involved in nucleic acid 
metabolism (Dreyfuss et al. 1993). hnRNP K is essential for axonogenesis in Xenopus 
(Liu & Szaro 2011) and its inactivation, coupled with activation of the neuronal Hu-p21 
pathway, may be essential to the switch from proliferation to differentiation in NSC (Yano 
et al. 2005). The activity of hnRNP K is regulated by several PTM (reviewed in Lu & Gao 
2017), but S-nitrosylation is still yet to be described.  
EF-1 and EF-1 are part of the EF 1 complex, which is responsible for translation 
elongation. EF-1 delivers aa-tRNAs to the A site of the ribosome (Carvalho et al. 1984) 
and EF-1 replaces EF-1-bound GDP for GTP (Pittman et al. 2006). EF-1 and its 
regulation are essential for the function of EF-1. Although a role in neurogenesis is not 
described, EF-1 can interact with and regulate Akt (Pecorari et al. 2009, Khwanraj et 
al. 2016), a pathway involved in the proliferation of NSC (Peltier et al. 2007, Le Belle et 
al. 2011). EF-1 can be regulated by phosphorylation (Venema et al. 1991), but its S-
nitrosylation has not been previously described. 
PEBP-1 regulates the ERK/MAPK pathway, preventing MEK phosphorylation by binding 
to c-Raf (Yeung et al. 1999), and its overexpression increases neuronal differentiation, 
both in a human neuroblastoma cell line (Hellmann et al. 2010) and in adult rat 
Chapter 1 
 22 
hippocampal progenitor cells (Sagisaka et al. 2010). PEBP-1 is regulated by 
phosphorylation (Corbit et al. 2003), but its S-nitrosylation has not been described. Its 
role in neurogenesis is therefore interesting to study in more detail, so we focused more 
our study in this protein. 
 
 
 
Figure 1.6 - ERK/MAPK pathway signaling through EGFR. Upon ligand binding (EGF), its 
receptor (EGFR) dimerizes and becomes activated by autophosphorylation. p21Ras is activated 
by adaptor proteins (not represented) and the downstream protein kinases are sequentially 
activated by phosphorylation, namely c-Raf, MEK and ERK. ERK can be translocated to the 
nucleus or interact with other proteins that are then translocated. In the nucleus, gene expression 
can be altered and lead to cell proliferation. 14-3-3 , PCNA, hnRNP K and PEBP-1 are involved 
in different steps of this signaling pathway.  
 
1.2.3.1.1. Phosphatidylethanolamine-binding protein 1 (PEBP-1) 
PEBP-1 belongs to a family of proteins characterized by having a conserved region that 
was a binding site for the phospholipid O-phosphatidylethanolamine (Serre et al. 1998). 
It is a highly conserved family of proteins, existing in organisms that range from bacteria 
to mammals. PEBP-1 gene is composed of 4 exons localized in mouse chromosome 5, 
and human and rat chromosome 12. Knockout mice for PEBP-1 revealed that PEBP-1 
is mainly expressed in testis and in the brain, mostly in structures of the limbic system, 
including the hippocampus (Theroux et al. 2007). These animals are viable but develop 
olfactory deficits. The protein has 187 aminoacids, of which in mouse 3 are cysteines 
(13, 133 and 168). Human and rat PEBP-1 have 2 cysteines (133 and 168). Cleavage 
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of the N-terminal of PEBP-1 originates the hippocampal cholinergic neurostimulating 
peptide, which corresponds to PEBP-1 aminoacids 2-12, and increases production of 
choline acetyltransferase in the hippocampus (Ojika et al. 2000). 
PEBP-1 is involved in the regulation of different signaling pathways (Fig. 1.7). It is also 
called raf kinase inhibitory protein (RKIP) because it regulates the ERK/MAPK pathway 
by binding to c-Raf and MEK, preventing their association and phosphorylation of MEK, 
which results in inhibition of the signaling pathway (Yeung et al. 1999, Yeung et al. 2000). 
Phosphorylation of PEBP-1 serine 153 by protein kinase C (PKC) releases the 
association between PEBP-1 and c-Raf (Corbit et al. 2003) and triggers dimerization of 
PEBP-1, increasing its specificity for binding and inhibiting G protein-coupled receptor 
kinase 2 (GRK2) ability to phosphorylate G protein-coupled receptors (Lorenz et al. 
2003, Deiss et al. 2012). PEBP-1 also regulates the NFB pathway by interacting with 
several kinases, acting as a scaffold protein, and both its overexpression and 
downregulation impair the degradation of inhibitory B upon stimulation by IL-1β (Yeung 
et al. 2001, Tang et al. 2010). Glycogen synthase kinase 3  signaling can be directly 
activated by PEBP-1, through prevention of its inhibition by phosphorylation (Al-Mulla et 
al. 2011). 
In the brain, PEBP-1 has different functions, such as mediating PKC-dependent MAPK 
activation during cerebellar long-term depression (Yamamoto et al. 2012). Several 
studies show that PEBP-1 is important for neurogenesis. Hippocampal progenitor cells 
secrete PEBP-1 to culture medium (Dahl et al. 2003). Moreover, PEBP-1 is involved in 
directing differentiation of hippocampal progenitor cells and neuroblastoma cells towards 
a neuronal lineage (Sagisaka et al. 2010, Hellmann et al. 2010) through enhanced 
crosstalk of PKC and ERK/MAPK and enhancement of G protein-coupled receptor 
signaling (Hellmann et al. 2010). In neuroblastoma cells, long-term ethanol exposure 
impairs neuronal differentiation, which is accompanied by downregulation of PEBP-1 and 
PKC, and by decreased activation of the ERK/MAPK pathway by BDNF (Hellmann et al. 
2009). In an ischemic model, PEBP-1 regulates differentiation towards a neuronal 
lineage and decreases differentiation into astrocytes, in the hippocampus (Toyoda et al. 
2012). 
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Figure 1.7 - PEBP-1 regulates several signaling pathways. PEBP-1 inhibits ERK/MAPK 
pathway signaling by binding to c-Raf and MEK, and by preventing phosphorylation of MEK by c-
Raf. Upon activation through G protein-coupled receptor (GPCR), PKC phosphorylates serine 
153 of PEBP-1. This induces the release of PEBP-1 inhibitory effect in the ERK/MAPK pathway, 
and prevents the inhibitory effect of GRK2 in GPCR signaling. PEBP-1 can also regulate NFB 
signaling by preventing degradation of inhibitory B, and can activate glycogen synthase kinase 
3  (GSK3) by preventing its inhibitory phosphorylation.  
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1.3. Objectives 
Post-injury neurogenesis is not an efficient process, which impairs the potential of brain 
regeneration. NO is an important regulator of adult neurogenesis, being able to enhance 
the proliferation of NSC in conditions of neuroinflammation. One of the ways by which 
NO can produce its effects is by inducing S-nitrosylation of proteins by reacting with thiol 
groups of cysteine residues. A mechanism of activation of the ERK/MAPK pathway 
through S-nitrosylation by NO and enhancement of proliferation of NSC has been 
described by our group (Santos et al. 2017). Moreover, our group also recently identified 
a group of proteins that are S-nitrosylated by NO in NSC (Ana I. Santos, unpublished 
results). Some of these proteins are involved in cell proliferation by interacting with the 
ERK/MAPK pathway. PEBP-1, one of the identified targets, is a regulator of cell 
proliferation by means of c-Raf inhibition, being a promising target to study in detail. In 
this work, we propose to investigate the role of PEBP-1 S-nitrosylation by NO in 
neurogenesis, particularly in the proliferation of NSC. In addition, we also propose to 
investigate the biological role of the other newly identified targets of S-nitrosylation of NO 
in post-injury neurogenesis. 
The methods used in this work are described in detail in chapter 2. 
In chapter 3.1, the role of S-nitrosylation of PEBP-1 by NO in proliferation was evaluated 
in SVZ-derived NSC using normal or NO-insensitive forms of PEBP-1, lacking specific 
cysteines. The contribution of each cysteine for S-nitrosylation of PEBP-1, and its effect 
on ERK/MAPK signaling and cell proliferation was evaluated, after treatment with the S-
nitrosothiol CysNO or the NO donor NOC-18. Moreover, S-nitrosylation of PEBP-1 in 
post-injury neurogenesis was evaluated using a mouse model of excitotoxic brain lesion 
associated with increased hippocampal neurogenesis mediated by NO (Carreira et al. 
2015). S-nitrosylation of PEBP-1 was assessed in the DG of wild type mice and mice 
lacking iNOS, and also in the stem cells of the DG, using cultured hippocampal stem 
cells treated with CysNO.  
In chapter 3.2, the role of S-nitrosylation of the other identified proteins by NO in post-
injury neurogenesis was evaluated using the mouse model described above. S-
nitrosylation of 14-3-3, hnRNP K, PCNA and EF-1 was assessed in mouse DG, and in 
hippocampal stem cells treated with CysNO.  
Chapter 4 includes an integrated discussion of the results presented in this work, and 
chapter 5 presents the conclusions. 
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2.1. Methods 
2.1.1. Animals 
C57Bl6 male mice were purchased from Charles River (Barcelona, Spain), and 
B6.129P2- Nos2tm1Lau/J (knockout for iNOS, iNOS KO) male mice were purchased from 
The Jackson Laboratory (Bar Harbor, ME, USA). The animals were kept in the animal 
facilities of Center for Neuroscience and Cell Biology (Coimbra) and Center for 
Biomedical Research (University of Algarve, Faro) with food and water ad libitum in a 
12-hour dark:light cycle. All experiments were performed in accordance with institutional 
and European guidelines (2010/63/EU and DL 113/2013) for the care and use of 
laboratory animals, under the project license 0421/000/000/2013. 
 
2.1.2. Genotyping 
The genotype of B6.129P2-Nos2tm1Lau/J mice was confirmed by polymerase chain 
reaction, using the primers recommended by The Jackson Laboratory (Table 2.1) and 
NZYTaq 2x Green Master Mix. DNA was obtained from the tip of the tail, after purification 
with NZY Tissue gDNA Isolation kit. After denaturation at 94C for 5 min, 35 cycles of 
94C, 55C and 72C for 1 min each were performed, followed by a final extension at 
72C for 10 min.  
 
Table 2.1 - Primer sequences for genotyping. 
 DNA sequence (5’-3’) 
iNOS 
ACA TGC AGA ATG AGT ACC GG 
TCA ACA TCT CCT GGT GGA AC 
AAT ATG CGA AGT GGA CCT CG 
 
The amplicons were run in a gel electrophoresis (2% agarose with GreenSafe Premium), 
and were detected using ChemiDoc XRS+ (BioRad Laboratories Inc., Hercules, CA, 
USA), resulting in a product of 108 base pairs for the wild type allele, and a product of 
270 base pairs for the recombinant allele (Fig. 2.1). 
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Figure 2.1 - Genotyping profile of WT and iNOS KO mice. Representative image of PCR 
products of wild type (WT) and iNOS KO mice genotyping. 
 
2.1.3. SVZ-derived NSC cultures 
NSC were isolated from the SVZ of P0-3 C57Bl6 mice as previously described (Morte et 
al. 2013). Briefly, mice were decapitated, the brain and meninges were removed, and 
slices of 1 mm were cut coronally. Tissue lining the lateral walls of the lateral ventricles 
was dissected and enzymatically digested in 0.025% Trypsin/0.265 mM 
ethylenediaminetetraacetic acid (EDTA) in Hanks' Balanced Salt Solution, 15 min at 
37C. Single cells were counted using 0.1% trypan blue exclusion assay and plated in 
uncoated T-25 flasks at a density of 100,000 cells/ml. NSC were allowed to grow as 
floating aggregates (neurospheres) in proliferation medium (Dulbecco’s modified eagle 
medium: nutrient mixture F-12 (D-MEM/F-12) with 2 mM GlutaMAXTM-I (L-Ala-L-Gln) 
supplemented with 1% B27, 1% antibiotic (PenStrep, 10,000 units/ml of penicillin, 10 
mg/ml streptomycin), 5 ng/ml bFGF and 10 ng/ml EGF, in 95% air/5% CO2 humidified 
atmosphere at 37C. Approximately 5 days later, NSC were mechanically dissociated 
and resuspended in fresh proliferation medium (passage). After at least 2 passages, 
NSC were plated on 0.1 mg/ml poly-L-lysine-coated multiwells or coverslips, and 
maintained with proliferation medium until the desired confluency was achieved. Each 
culture was used until reaching a maximum of 12 passages. 
 
2.1.4. Hippocampal stem cell cultures 
Hippocampal stem cells were kindly provided by Dr. Fred H. Gage (Salk institute, USA). 
These cells were isolated from the hippocampus of adult Fischer 344 rats, as described 
by Gage et al. (1995), and their capacity for self-renewal and multipotency was 
characterized by Palmer et al. (1997). For maintenance of the cell line, hippocampal 
stem cells were cultured adherent on plates coated with polyornithine (10 µg/ml) and 
laminin (10 µg/ml), in D-MEM/F-12 with 2 mM GlutaMAXTM-I (L-Ala-L-Gln) supplemented 
with 1% PenStrep, 1% N2 and 20 ng/ml bFGF, and in 95% air/5% CO2 humidified 
atmosphere at 37C. Culture medium was replaced every 3-4 days and, when confluent, 
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cells were detached using 0.25% Trypsin/EDTA for 1 min at 37C. After centrifugation at 
1,000 rpm for 5 min, cells were resuspended in fresh culture medium and allowed to 
grow. 
 
2.1.5. Mutagenesis of PEBP-1 
To overexpress PEBP-1, a commercially available plasmid of pCMV-SPORT6 backbone 
with mouse PEBP-1 cDNA was purchased (Thermo Scientific, Waltham, MA, USA). To 
replace cysteine for serine, the nucleotide cytosine was changed to guanine. For each 
of the 3 cysteines of PEBP-1, two complementary oligonucleotides, containing the 
necessary mutation, were designed using QuikChange Primer Design Program (Agilent 
Technologies, Santa Clara, CA, USA), synthesized and purified (Table 2.2). 
QuickChange II XL Site-Directed Mutagenesis Kit was used to induce the mutations, 
following the manufacturer’s instructions. Briefly, polymerase chain reaction 
amplification was performed with an initial denaturation of 95°C for 1 min, followed by 18 
cycles of 95°C for 50 s, 60°C for 50 s and 68°C for 5 min, followed by an overall extension 
at 68°C for 7 min. The amplicons were then digested with Dpn I for 1 h at 37°C. Bacterial 
transformation was performed by inducing a heat-pulse in a 42°C water bath for 30 s, 
followed by a 2 min-incubation on ice. Bacteria were left to grow at 37°C with shaking at 
230 rpm, for 1 h. After selection on agar plates with 100 g/ml ampicillin, 2 colonies were 
picked, and plasmid DNA was purified with NZYMiniprep and sequenced by Stab Vida 
(Caparica, Portugal). One clone of each mutant was chosen and expanded, after which 
DNA was purified with Endotoxin-free Plasmid DNA Purification and 
spectrophotometrically quantified at 260/280 nm with NanoDrop 2000C (Thermo 
Scientific, Waltham, MA, USA). 
 
Table 2.2 - Primer sequences for PEBP-1 mutagenesis.  
 DNA sequence (5’-3’) 
C13S 
CCG GGC CCT TGT CCT TGC AGG AGG T 
ACC TCC TGC AAG GAC AAG GGC CCG G 
C133S 
AGC CGC TGA GCT CCG ACG AGC CC 
GGG CTC GTC GGA GCT CAG CGG CT 
C168S 
GGC GGG CAC GTC CTA CCA AGC CG 
CGG CTT GGT AGG ACG TGC CCG CC 
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2.1.6. PEBP-1 overexpression 
NSC were transfected with the PEBP-1 constructs using Lipofectamine LTX following 
the manufacturer’s instructions. Briefly, NSC were plated until reaching 70% of 
confluency, and culture medium was replaced with proliferation medium without 
antibiotic (PenStrep) in the day of transfection. DNA (1.5 g) and Plus Reagent (2.5 l) 
were added to Opti-MEM I reduced serum medium, and after 10 min Lipofectamine LTX 
(2 l) was added. Complexes were formed during 30 min, after which they were added 
to cells drop-by-drop and left for 30-48 h. Culture medium was replaced by medium 
without growth factors (EGF and bFGF) 24 h before cell treatment. In cell signaling 
analysis and proliferation experiments, NSC overexpressing PEBP-1 were identified by 
immunocytochemistry.  
 
2.1.7. Synthesis of S-nitrosocysteine 
CysNO synthesis was prepared as previously described (Jourd'heuil et al. 2000). 1 
volume of L-Cysteine (200 mM in 1 M HCl) was mixed with 1 volume of NaNO2 (200 
mM) and kept in the dark. After 30 min at room temperature (RT), 2 volumes of 
K2HPO4 buffer (1 M, pH=7.4) were added. From that point on, the solution was kept on 
ice until storage at -80°C. Concentration was calculated using the extinction coefficient 
of 900 M-1 cm-1 at an absorbance of 338 nm (DeMaster et al. 1995), measured in 
NanoDrop 2000C (Thermo Scientific, Waltham, MA, USA). 
 
2.1.8. Experimental treatments 
Cell treatment was performed 24 h after changing the culture medium for medium without 
growth factors. To evaluate S-nitrosylation of PEBP-1, NSC were exposed to a S-
nitrosothiol (CysNO, 100 M) for 1, 2 and 15 min, and a NO donor (NOC-18, 10 M) for 
2.5, 5, 7.5 and 10 min. To evaluate protein oxidation, NSC were treated with CysNO (100 
M) and DEA/NO (100 M and 1 mM) for 15 min, and NOC-18 (10 M) for 1 h. In 
hippocampal stem cells, S-nitrosylation of proteins was evaluated after treatment with 
CysNO at different concentrations (10, 50 and 100 M) for 15 min. To analyze cell 
signaling, NSC were treated with CysNO (10 M) for 5 min and EGF (20 ng/ml) for 20 
min. To evaluate cell proliferation, NSC were treated with NOC-18 (10 M) for 1 h. 
 
2.1.9. Evaluation of cell proliferation by incorporation of EdU 
To evaluate cell proliferation, 5-ethynyl-2’-deoxyuridine (EdU, 10 M), a thymidine 
analogue that incorporates in DNA in the S phase of cell division, was added to cultures 
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for 1 h. NSC were rinsed in 0.01 M phosphate-buffered saline (PBS, 7.8 mM 
Na2HPO4.2H2O, 2.7 mM NaH2PO4.H2O, 154 mM NaCl, pH 7.2) and fixed for 20 min with 
4% paraformaldehyde/4% sucrose in PBS. EdU was detected by click chemistry 
reaction, a copper-mediated covalent coupling of the ethynyl group of EdU with a 
fluorescent dye-conjugated azide, using Click-iT EdU Alexa Fluor 488 HCS Assay Kit, 
following the manufacturer’s instructions. Nuclei were labeled with Hoechst 33342 (1 
g/ml) for 5 min. Cells that incorporated EdU were detected by fluorescence microscopy 
(Axioimager Z2 APOTOME, Zeiss, Gena, Germany). The whole coverslip of each 
condition was analyzed for EdU-positive transfected cells. Ten representative images 
were randomly acquired for each coverslip, averaging around 500 analyzed cells per 
condition. The number of non-transfected cells that incorporated EdU of the total non-
apoptotic cells was counted using ImageJ (version 1.47v, National Institutes of Health, 
Bethesda, MD, USA). 
 
2.1.10. Immunocytochemistry 
Overexpression of PEBP-1 and levels of phosphorylated ERK (P-ERK) were analyzed 
by immunocytochemistry. NSC were rinsed in PBS and fixed with 4% 
paraformaldehyde/4% sucrose in PBS for 20 min. After being rinsed in PBS, cells were 
permeabilized with 0.5% Triton X-100 for 15 min and blocked in 3% bovine serum 
albumin (BSA)/0.2% Tween 20 for 1 h. Primary antibodies (Table 2.3) were incubated 
overnight at 4C and, after rinsing with PBS, secondary antibodies (Table 2.4) were 
incubated for 1 h 30 at RT. Nuclei were labeled with Hoechst 33342 (1 g/ml, 5 min). 
Coverslips were mounted with DAKO fluorescence mounting medium on slides. At 
least 5 representative images were obtained using Axioimager Z2 APOTOME or LSM 
710 confocal (Zeiss, Jena, Germany). Fluorescence of P-ERK was analyzed using 
ImageJ (version 1.47v, National Institutes of Health, Bethesda, MD, USA) to measure 
the mean gray value of the green channel, in transfected cells, as previously described 
(Santos et al. 2017). 
 
Table 2.3 - Primary antibodies used in immunocytochemistry 
Antibody Host Dilution Company Reference 
PEBP-1 Goat 1:500 Abcam ab2634 
P-ERK Rabbit 1:50 Cell Signaling 4370 
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Table 2.4 - Secondary antibodies used in immunocytochemistry 
Antibody Host Dilution Company Reference 
Anti-goat Alexa Fluor 
594 
Donkey 1:200 Invitrogen A11058 
Anti-rabbit Alexa Fluor 
488 
Donkey 1:200 Invitrogen A21206 
 
2.1.11. Western Blot analysis 
To analyze PEBP-1 levels by Western Blot, cytosolic protein lysates were prepared after 
treatment, as previously described (Carreira et al. 2010). NSC were rinsed with cold 
PBS, and scrapped with cold lysis buffer (100 mM Tris-HCl, 10 mM ethylene glycol 
tetraacetic acid, 1% Triton X-100 and 2 mM MgCl2) supplemented with protease and 
phosphatase inhibitors, and dithiothreitol (DTT, 1 mM). Samples were sonicated 6 times 
for 2 s with pauses of 4 s, and centrifuged at 15,800 g for 10 min at 4C. Supernatant 
was collected and protein quantification was performed with BCA Protein Assay following 
the manufacturer’s instructions. 
Protein samples were denatured for 5 min at 95C after addition of 6x concentrated 
Sample buffer (0.5 M Tris-HCl/0.4 % sodium dodecyl sulfate (SDS) pH 6.8, 30 % 
glycerol, 10 % SDS, 0.6 M DTT, 0.012 % bromophenol blue), and separated by 
electrophoresis in a 12% acrylamide gel. Proteins were then transferred to a 
polyvinylidene difluoride (PVDF) membrane using Trans-Blot
® 
TurboTM Transfer System 
(BioRad Laboratories Inc., Hercules, CA, USA) for 10 min. Membranes were blocked 
with 3% BSA in Tris-buffered saline with tween 20 (TBS-T) for 1 h at RT. PEBP-1 primary 
antibody (Table 2.5) was incubated overnight at 4C. After washing with TBS-T, anti-
goat HRP conjugate (Table 2.6) was incubated 1 h at RT. NZY Supreme ECL HRP 
Substrate was added to the membranes during 5 min and chemiluminescence was 
detected using ChemiDoc XRS+ (BioRad Laboratories Inc., Hercules, CA, USA). The 
images were acquired and analyzed with ImageLab 5.0 (BioRad Laboratories Inc., 
Hercules, CA, USA). 
 
2.1.12. Preparation of cell protein lysates for fluorescence switch and biotin switch 
assays 
After rinsing with cold 0.9% NaCl pH=7.4, cells were scrapped in cold TENT (50 mM Tris 
pH 7.2, 1 mM EDTA, 0.1 mM neocuproine, 1% Triton X-100) supplemented with protease 
inhibitors and 50 mM N-ethylmaleimide. Membrane proteins were removed with a 
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centrifugation of 10,760 g for 10 min at 4C, and 2% SDS was added to the cytosolic 
samples. Free thiols (SH) were blocked with N-ethylmaleimide (50 mM) for 30 min at 
37C, and protein was quantified using BCA Protein Assay, following the manufacturer’s 
instructions. The protocol was performed protected from light. 
 
2.1.13. Fluorescence switch assay 
To evaluate protein oxidation (Fig. 2.2A), 50 g of protein were used and processed as 
previously described (Izquierdo-Alvarez et al. 2012). Protein was precipitated  in 3 
volumes of acetone for 10 min at -20C and centrifuged at 10,760 g for 5 min at 4C. 
The supernatant was discarded and the pellet resuspended in 2.5 mM DTT. After 
reduction for 10 min at RT, protein was precipitated as before, and resuspendend in 
TENS (50 mM Tris pH 7.2, 1 mM EDTA, 0.1 mM neocuproine, 1% SDS) with 40 M 
BODIPY FL maleimide. Binding to free thiols (SH) was performed for 1 h at RT, stopped 
with addition of 2.5 mM DTT, and followed by acetone precipitation. To evaluate protein 
S-nitrosylation (Fig. 2.2B), 100 g of protein were used. After protein precipitation, the 
pellet was resuspended in TENS with 100 mM sodium ascorbate and 40 M BODIPY 
FL maleimide. Binding to free thiols (SH) was performed for 1 h at RT, stopped with 
addition of 4 mM N-ethylmaleimide, and followed by acetone precipitation. To analyze 
by SDS-PAGE, samples were resuspended in 2x non-reducing Laemmli buffer (100 mM 
Tris pH 7.6, 8 mM EDTA, 2% SDS, 20% glycerol, 0.04% Bromophenol blue) and run in 
a 10% acrylamide gel. Fluorescence was detected in ChemiDoc XRS+ (BioRad 
Laboratories Inc., Hercules, CA, USA), and images acquired using ImageLab 5.0 
(BioRad Laboratories Inc., Hercules, CA, USA). Until this point, the protocol was 
performed in the dark. To stain the total protein, gel was fixed in 50% methanol/7% acetic 
acid for 15 min, and stained with 0.2% Coomassie Blue (45% methanol/10% acetic acid) 
for 1 h. After washing in 10% methanol/7% acetic acid for 30 min, gel was washed in 
water, and images were acquired in ChemiDoc XRS+ (BioRad Laboratories Inc., 
Hercules, CA, USA), using ImageLab 5.0 (BioRad Laboratories Inc., Hercules, CA, 
USA).  
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Figure 2.2 - Scheme of the fluorescence switch assay. Protein free thiol groups are blocked 
with N-ethylmaleimide (NEM), followed by reduction of oxidized groups by DTT (A) or S-
nitrosylated groups by ascorbate (asc) (B) to free thiols. BODIPY FL maleimide is then able to 
bind to the free thiols. 
 
2.1.14. Mouse model of kainic acid-induced seizures 
To validate the targets of S-nitrosylation, a model of seizures epilepsy caused by kainic 
acid (KA) was used as a mouse model of post-injury neurogenesis. KA is an agonist of 
AMPA/kainate class of glutamate receptors. Injection of KA induces seizures and 
excitotoxicity, which results in neuronal degeneration in the CA1 and CA3 regions of the 
hippocampus (Schauwecker & Steward 1997). This model is characterized by increased 
neurogenesis in the DG after seizures (Parent 2007), which can be prevented in the 
absence of NO release by iNOS (Carreira et al. 2010). 
C57Bl6 (wild type, WT) and B6.129P2- Nos2tm1Lau/J (knockout for iNOS, iNOS KO) male 
mice with 12 weeks were subcutaneously injected with KA solution (25 mg/kg) or with 
saline solution (0.9% NaCl, control, SAL). Rating of seizures was performed according 
to the modified Racine scale as previously described (Schauwecker & Steward 1997): 
stage I - immobility, stage II - tail extension/forelimb/rigid posture, stage III - repetitive 
movements/ head bobbing, stage IV - rearing and falling, stage V - continuous rearing 
and falling, stage VI - tonic-clonic seizures. Only mice that reached epileptic seizures of 
stage V or VI were used in the experiment. After injection (1, 2, 3 and 5 days), mice were 
sacrificed by cervical dislocation, decapitated, the brain was removed and the DG 
dissected from the hippocampus. 
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2.1.15. Preparation of tissue protein lysates for biotin switch assay 
To evaluate protein S-nitrosylation, proteins were extracted from the dissected mouse 
DG. Until binding of biotin, the protocol was performed in the dark, as previously 
described (Santos et al. 2017). Tissue was lysed by manually homogenizing with a tissue 
grinder, in cold TENT (50 mM Tris pH 7.2, 1 mM EDTA, 0.1 mM neocuproine, 0.5% 
Triton X-100) supplemented with protease inhibitors and 50 mM N-ethylmaleimide. 
Samples were sonicated 4 times for 2 s with 6 s pauses, and 2% SDS was added. Free 
thiols (SH) were blocked with N-ethylmaleimide (50 mM) during 30 min at 37C, and 
protein was quantified using BCA Protein Assay, following the manufacturer’s 
instructions. 
 
2.1.16. Biotin switch assay 
Biotin switch assay allows the identification of protein oxidation or S-nitrosylation, 
depending on the reducing agent used: DTT for oxidation (Fig. 2.3A) and ascorbate for 
S-nitrosylation (Fig. 2.3B). Detection of oxidation requires less amount of protein and is 
more sensitive, thus being easier to detect.  
Evaluation of oxidation was performed using 250 g of protein, and of S-nitrosylation 
was performed using 500 g for cell cultures, and 1000 g for DG lysates, as previously 
described (Santos et al. 2017). Until binding of biotin, the protocol was performed in the 
dark. Protein was precipitated with acetone at -20C for 10 min and centrifuged at 10,760 
g for 10 min. Pelleted protein was resuspended in TENS (50 mM Tris pH 7.2, 1 mM 
EDTA, 0.1 mM neocuproine, 1% SDS). For detection of oxidation, 2.5 mM DTT was 
added and incubated for 10 min at RT. After acetone precipitation, samples were 
resuspended in TENS with 1 mM Biotin-HPDP for 1 h at RT. DTT reduced oxidized thiols 
(SOx), including disulfide bonds, to free thiols (SH), leaving them available to bind Biotin-
HPDP. For detection of S-nitrosylation, 100 mM sodium ascorbate and 1 mM Biotin-
HPDP were added to TENS, and incubated for 1 h at RT. Ascorbate reduced S-
nitrosylated thiols (SNO) to free thiols (SH), leaving them available to bind Biotin-HPDP. 
Protein was again precipitated with acetone at -20C for 10 min, centrifuged at 10,760 g 
for 10 min, and resuspended in HENS (250 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) pH 7.7, 1 mM EDTA, 0.1 mM neocuproine, 1% 
SDS) and Jaffrey’s (20 mM HEPES pH 7.7, 100 mM NaCl, 1 mM EDTA, 0.5% Triton X-
100). After centrifugation at 12,020 g for 2 min, a portion of the supernatant was saved 
(total protein). NeutrAvidin Plus UltraLink resin was equilibrated by addition of 
Equilibration buffer (20 mM HEPES pH 7.7, 100 mM NaCl, 1 mM EDTA) and 
centrifugation at 1,790 g for 1 min, 3 times. The remaining protein supernant was added 
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to the resin and left for 2 h in agitation, so that proteins bound to biotin (initially oxidized 
or S-nitrosylated) were retained in the resin, due to the high-affinity binding of biotin to 
neutravidin. The supernatant containing the proteins not bound to the resin was saved 
(non-retained protein). Samples were washed 3 times with Washing buffer (20 mM 
HEPES pH 7.7, 600 mM NaCl, 1 mM EDTA, 0.5% Triton X-100), 1 time with Equilibration 
buffer, and centrifuged at 1,790 g for 1 min each time. Proteins were released from the 
resin with Elution buffer (Equilibration buffer with 100 mM -mercaptoethanol) for 20 min 
at 37C, by disruption of biotin-protein binding due to -mercaptoethanol. After 
centrifugation at 12,020 g for 1 min, the supernatant was saved (eluted protein) and 
concentrated using Vacuum Concentrator 5301 (Eppendorf, Hamburg, Germany) at 
30C in vacuum, in order to fit the well of the immunoblot gel. 
To evaluate the outcome of the protocol by analyzing the presence or absence of biotin 
in total protein and non-retained protein, respectively, 4x non-reducing Laemmli buffer 
(200 mM Tris pH 7.6, 8 mM EDTA, 4% SDS, 40% glycerol, 0.08% Bromophenol blue) 
was added to a portion of these samples. Proteins were separated by electrophoresis in 
a 10% acrylamide gel, and transferred to a PVDF membrane using Trans-Blot® 
TurboTM Transfer System (BioRad Laboratories Inc., Hercules, CA, USA) for 10 min. 
Membranes were blocked in 3% BSA in TBS-T for 1 h at RT, and incubated with 
Streptavidin, Peroxidase conjugate (1:2,000) for 30 min at RT. After washing with TBS-
T, NZY Supreme ECL HRP Substrate was added to the membranes for 5 min. 
Chemiluminescence was detected using ChemiDoc XRS+ (BioRad Laboratories Inc., 
Hercules, CA, USA), and the images were acquired with ImageLab 5.0 (BioRad 
Laboratories Inc., Hercules, CA, USA). 
To analyze oxidation and S-nitrosylation, total protein and eluted protein samples were 
denatured for 5 min at 95C after addition of reducing 4x Laemmli buffer with 20% -
mercaptoethanol, and separated by electrophoresis in a 12% acrylamide gel. Proteins 
were then transferred to a PVDF membrane using Trans-Blot
® 
TurboTM Transfer System 
(BioRad Laboratories Inc., Hercules, CA, USA) for 10 min. Membranes were blocked 
with 3% BSA or 5% milk in TBS-T for 1 h at RT. Primary antibodies were incubated 
overnight at 4C (Table 2.5), except for hnRNP K that was incubated 48 h at 4C. After 
washing with TBS-T, secondary antibodies (Table 2.6) were incubated 1 h at RT. NZY 
Supreme ECL HRP Substrate was added to the membranes for 5 min and 
chemiluminescence was detected using ChemiDoc XRS+ (BioRad Laboratories Inc., 
Hercules, CA, USA). The images were acquired and analyzed with ImageLab 5.0 
(BioRad Laboratories Inc., Hercules, CA, USA). Levels of oxidized/S-nitrosylated protein 
were normalized with levels of total protein. 
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Figure 2.3 - Scheme of the biotin switch assay. Protein free thiol groups are blocked with N-
ethylmaleimide (NEM), followed by reduction of oxidized groups by DTT (A) or S-nitrosylated 
groups by ascorbate (asc) (B) to free thiols. Biotin is then able to bind to the free thiols. 
 
Table 2.5 - Primary antibodies used in Western Blot 
Antibody Host Dilution Company Reference 
hnRNP K Rabbit 1:1,000 Cell Signaling 4675S 
PCNA Mouse 1:500 
Santa Cruz 
Biotechnology 
sc-56 
14-3-3 Rabbit 1:1,000 Cell Signaling 8312S 
14-3-3  Rabbit 1:1,000 Cell Signaling 9769S 
EF-1 Goat 1:500 
Santa Cruz 
Biotechnology 
sc-82870 
PEBP-1 Goat 1:10,000 Abcam ab2634 
 
 
Table 2.6 - Secondary antibodies used in Western Blot 
Antibody Host Dilution Company Reference 
Anti-goat HRP conjugate Donkey 1:2,000 
Life 
Technologies 
A15999 
Anti-rabbit HRP 
conjugate 
Goat 1:2,000 Cell Signaling 7074 
Anti-mouse HRP 
conjugate 
Donkey 1:2,000 Cell Signaling 7076S 
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2.1.17. Statistical analysis 
Statistical analysis was performed using GraphPad Prism 6.0 with One-way analysis 
of variance (ANOVA) followed by Dunnett’s or Bonferroni’s post-hoc tests, Two-way 
ANOVA and Two-tailed Student’s t-test, as indicated in the figure legends. p<0.05 was 
considered statistically significant.  
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2.2. Materials 
Trypsin-EDTA, DMEM-F12 GlutaMAX, B27, N2, PenStrep, Opti-MEM I reduced serum 
medium, Lipofectamine LTX, laminin, Click-iT EdU Alexa Fluor 488 HCS Assay Kit, 
Hoechst 33342, BODIPY FL maleimide, BCA Protein Assay, Biotin-HPDP and 
NeutrAvidin Plus UltraLink resin were purchased from Thermo Fisher Scientific 
(Waltham, MA, USA). bFGF and EGF were acquired from PeproTech (London, UK). 
Trypan blue, poly-L-lysine, polyornithine, HBSS, N-ethylmaleimide, neocuproine, sodium 
ascorbate, Tween 20, coomassie blue, methanol, HEPES, HBSS, MgCl2, EGTA, EDTA, 
glycerol, acetone, Ampicillin, diethylamine NONOate (DEA/NO) and -mercaptoethanol 
were purchased from Sigma Aldrich (St Louis, MO, USA). Primers, NZYMiniprep, NZY 
Supreme ECL HRP Substrate, NZY Tissue gDNA Isolation kit, NZYTaq 2x Green Master 
Mix, GreenSafe Premium, DTT, acrylamide, TEMED, ammonium persulfate, Tris and 
BSA were acquired from NZYTech (Lisboa, Portugal). 10% SDS, SDS, polyvinylidene 
difluoride (PVDF) membranes and 12% precast gels were from Bio Rad Laboratories 
Inc. (Hercules, CA, USA) and low-fat dry milk from Nestlé (Vevey, Switzerland). 
QuickChange II XL Site-Directed Mutagenesis Kit and DAKO fluorescence mounting 
medium were acquired from Agilent Tecnologies (Santa Clara, CA, USA). cOmplete 
miniprotease inhibitor cocktail and PhosSTOP phosphatase inhibitor cocktail were 
purchased from Roche Applied Science (Penzberg, Germany). DETA NONOate (NOC-
18) was acquired from Enzo Life Sciences Inc. (Farmingdale, NY, USA), Streptavidin, 
Peroxidase conjugate from Calbiochem (San Diego, CA, USA), and Endotoxin-free 
Plasmid DNA Purification from Macherey-Nagel (Duren, Germany). Kainic acid was from 
Ocean Produce International (Shelburne, Canada) and Tocris Bioscience (Bristol, UK). 
The origin of primary and secondary antibodies used in immunocytochemistry and 
Western Blot are listed in tables 2.3, 2.4, 2.5 and 2.6, respectively.  
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3.1. PEBP-1 as a target of S-nitrosylation 
3.1.1. S-nitrosylation of PEBP-1 in SVZ-derived NSC 
3.1.1.1. PEBP-1 is S-nitrosylated by NO in NSC 
To investigate if PEBP-1 was S-nitrosylated by NO in NSC, we first evaluated PEBP-1 
oxidation, which is easier to detect, more sensitive and requires less amount of protein 
than analysis of S-nitrosylation. NSC were treated for 15 min with CysNO (100 M) and 
oxidation was assessed by DTT-reducing biotin switch assay (Fig. 3.1A). We observed 
that treatment with CysNO increased the oxidation of PEBP-1, comparing with control 
(no treatment). 
Next, after NSC were treated for 15 min with CysNO (100 M), S-nitrosylation was 
evaluated by ascorbate-reducing biotin switch assay (Fig. 3.1B). We observed an 
increase in S-nitrosylation of PEBP-1 in treated cells, compared to control. 
Using shorter exposure periods, NSC were treated with CysNO (100 M, 1 and 2 min) 
and S-nitrosylation of PEBP-1 was evaluated by ascorbate-reducing biotin switch assay 
(Fig. 3.1C). We observed that exposure to CysNO during 1 min (3517.3  1017.3%, 
p<0.05) and 2 min (3905.9  1254.7%, p<0.05) significantly increased S-nitrosylation of 
PEBP-1 comparing with control. 
Using a NO donor at a concentration that stimulates proliferation of NSC (NOC-18, 10 
M; (Carreira et al. 2010)), NSC were treated for different times (2.5, 5, 7.5 and 10 min) 
with NOC-18 to investigate the S-nitrosylation of PEBP-1 by NO over time, assessed by 
ascorbate-reducing biotin switch assay (Fig. 3.1D). We observed that exposure to NOC-
18 for 2.5 min (197.3  45.4%), 5 min (158.5  19.2%) and 7.5 min (174.3  56.9%) 
showed a tendency to increase S-nitrosylation of PEBP-1 comparing with control. 
Exposure to NOC-18 for 10 min significantly increased S-nitrosylation of PEBP-1 (314.1 
 62.5%, p<0.05) comparing with control. 
It should be noted that the effect on S-nitrosylation of the NO donor NOC-18 is much 
more modest than the effect of CysNO, while nonetheless it is detectable and significant. 
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Figure 3.1 - Treatment of NSC with CysNO and NOC-18 induces S-nitrosylation of PEBP-1. 
SVZ-derived NSC were exposed to CysNO 100 µM for 15 (A, B), 1 and 2 min (C), and to NOC-
18 10 µM for 2.5, 5, 7.5 and 10 min (D). Oxidation (A) and S-nitrosylation (B-D) of PEBP-1 were 
evaluated by DTT-reducing (A) and ascorbate-reducing biotin switch assays (B-D). Data from 6-
8 (C) and 3-4 (D) independent experiments are presented as means ± SEM (% of control, 0, no 
treatment). One-way ANOVA (Dunnett’s post-hoc test), * p<0.05 significantly different from 
control (C, D). SOx PEBP-1, oxidized protein; SNO PEBP-1, S-nitrosylated protein. 
 
3.1.1.2. Mutagenesis of PEBP-1 
To investigate the role of PEBP-1 S-nitrosylation by NO in neurogenesis, we 
overexpressed PEBP-1 and NO-insensitive forms of PEBP-1 in NSC. Since mouse 
PEBP-1 has 3 cysteines, its tridimensional structure was analyzed in order to identify 
which of the cysteines would be more exposed and therefore would be more prone to 
react with NO. C13 (Fig. 3.2A) and C133 (Fig. 3.2B) are located at the surface of the 
protein, while C168 (Fig. 3.2C) is at the center of PEBP-1 tridimensional structure and 
less accessible; so it was speculated that mutation of C13 and C133 would produce NO-
insensitive PEBP-1, but not mutation of C168. Mutagenesis was performed switching a 
cysteine for serine, which is also a polar aminoacid but has a hydroxyl group instead of 
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a thiol group and therefore cannot be S-nitrosylated. We produced constructs with a 
single mutation of each cysteine (C13S, C133S and C168S), and a double mutant of the 
most exposed cysteines (C13S/C133S). 
 
 
 
Figure 3.2 - Localization of cysteine amino acids in mouse PEBP-1 tridimensional 
structure. Schematic representation of mouse PEBP-1 was obtained by similarity with rat PEBP-
1 crystal structure (Protein Data Bank), using SWISS-MODEL (Institute of Bioinformatics at the 
Biozentrum, University of Basel, Switzerland). Cysteines 13 (A), 133 (B) and 168 (C) are 
highlighted in yellow. In collaboration with Paulo Martel. 
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3.1.1.2.1. Construct C13S 
C13 was changed to a serine (Ser) by mutating the guanine nucleotide of that amino 
acid to a cytosine. Efficacy of this procedure was confirmed after sequencing PEBP-1 
C13S (C13S, Fig. 3.3A) and comparing it to the sequence of PEBP-1 WT (PEBP-1, Fig. 
3.3B). We observed that C13 had, in fact, been mutated to Ser and that no other 
mutations were introduced in the coding sequence of the gene. 
 
(A) C13S coding sequence 
ATG GCC GCC GAC ATC AGC CAG TGG GCC GGG CCC TTG TCC TTG CAG GAG GTG GAC 
GAG CCG CCC CAG CAC GCC CTG CGG GTC GAC TAC GCC GGG GTG ACG GTG GAC GAG 
CTG GGC AAA GTG CTA ACG CCC ACC CAG GTT ATG AAC AGG  CCC AGC AGC ATT TCA TGG 
GAC GGC CTT GAT CCT GGG AAA CTC TAC ACC CTG GTC CTC ACA GAC CCC GAT GCT CCC 
AGC AGG AAG GAT CCC AAA TTC AGG GAG  TGG CAC CAC TTC CTG GTG GTC AAC ATG AAG 
GGT AAT GAC ATT AGC AGT GGC ACT GTC CTC TCA GAT TAT GTG GGC TCC GGG CCT CCC 
AGT GGC ACA GGT CTC CAC CGC TAT GTC TGG CTG GTG TAC GAG CAG GAA CAG CCG CTG 
AGC TGC GAC GAG CCC ATT CTC AGC AAC AAG TCT GGA GAC AAT CGC GGC AAG TTC AAG 
GTG GAG ACC TTC CGC AAG AAG TAT AAC CTG GGA GCC CCG GTG GCG GGC ACG TGC 
TAC CAA GCC GAG TGG GAT GAC TAT GTG CCC AAG CTG TAC GAG CAG CTG TCA GGG AAG 
TAG 
Ser13; C133; C168 
 
(B) PEBP-1 coding sequence 
ATG GCC GCC GAC ATC AGC CAG TGG GCC GGG CCC TTG TGC TTG CAG GAG GTG GAC 
GAG CCG CCC CAG CAC GCC CTG CGG GTC GAC TAC GCC GGG GTG ACG GTG GAC GAG 
CTG GGC AAA GTG CTA ACG CCC ACC CAG GTT ATG AAC AGG CCC AGC AGC ATT TCA TGG 
GAC GGC CTT GAT CCT GGG AAA CTC TAC ACC CTG GTC CTC ACA GAC CCC GAT GCT CCC 
AGC AGG AAG GAT CCC AAA TTC AGG GAG TGG CAC CAC TTC CTG GTG GTC AAC ATG AAG 
GGT AAT GAC ATT AGC AGT GGC ACT GTC CTC TCA GAT TAT GTG GGC TCC GGG CCT CCC 
AGT GGC ACA GGT CTC CAC CGC TAT GTC TGG CTG GTG TAC GAG CAG GAA CAG CCG CTG 
AGC TGC GAC GAG CCC ATT CTC AGC AAC AAG TCT GGA GAC AAT CGC GGC AAG TTC AAG 
GTG GAG ACC TTC CGC AAG AAG TAT AAC CTG GGA GCC CCG GTG GCG GGC ACG TGC 
TAC CAA GCC GAG TGG GAT GAC TAT GTG CCC AAG CTG TAC GAG CAG CTG TCA GGG AAG 
TAG 
C13; C133; C168 
 
Figure 3.3 - Coding sequences of C13S (A) and PEBP-1 (B). After mutation of guanine 
nucleotide number 59 to a cytosine, sequencing of C13S was compared with the sequence of 
PEBP-1. Ser13: serine 13; C13: cysteine 13; C133: cysteine 133; C168: cysteine 168. 
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3.1.1.2.2. Construct C133S 
C133 was changed to Ser by mutating the guanine nucleotide of that amino acid to a 
cytosine. Efficacy of this procedure was confirmed after sequencing PEBP-1 C133S 
(C133S, Fig. 3.4A) and comparing it to the sequence of PEBP-1 WT (PEBP-1, Fig. 3.4B). 
We observed that C133 had, in fact, been mutated to Ser and that no other mutations 
were introduced in the coding sequence of the gene. 
 
(A) C133S coding sequence 
ATG GCC GCC GAC ATC AGC CAG TGG GCC GGG CCC TTG TGC TTG CAG GAG GTG GAC 
GAG CCG CCC CAG CAC GCC CTG CGG GTC GAC TAC GCC GGG GTG ACG GTG GAC GAG 
CTG GGC AAA GTG CTA ACG CCC ACC CAG GTT ATG AAC AGG  CCC AGC AGC ATT TCA TGG 
GAC GGC CTT GAT CCT GGG AAA CTC TAC ACC CTG GTC CTC ACA GAC CCC GAT GCT CCC 
AGC AGG AAG GAT CCC AAA TTC AGG GAG  TGG CAC CAC TTC CTG GTG GTC AAC ATG AAG 
GGT AAT GAC ATT AGC AGT GGC ACT GTC CTC TCA GAT TAT GTG GGC TCC GGG CCT CCC 
AGT GGC ACA GGT CTC CAC CGC TAT GTC TGG CTG GTG TAC GAG CAG GAA CAG CCG CTG 
AGC TCC GAC GAG CCC ATT CTC AGC AAC AAG TCT GGA GAC AAT CGC GGC AAG TTC AAG 
GTG GAG ACC TTC CGC AAG AAG TAT AAC CTG GGA GCC CCG GTG GCG GGC ACG TGC 
TAC CAA GCC GAG TGG GAT GAC TAT GTG CCC AAG CTG TAC GAG CAG CTG TCA GGG AAG 
TAG 
C13; Ser133; C168 
 
(B) PEBP-1 coding sequence 
ATG GCC GCC GAC ATC AGC CAG TGG GCC GGG CCC TTG TGC TTG CAG GAG GTG GAC 
GAG CCG CCC CAG CAC GCC CTG CGG GTC GAC TAC GCC GGG GTG ACG GTG GAC GAG 
CTG GGC AAA GTG CTA ACG CCC ACC CAG GTT ATG AAC AGG CCC AGC AGC ATT TCA TGG 
GAC GGC CTT GAT CCT GGG AAA CTC TAC ACC CTG GTC CTC ACA GAC CCC GAT GCT CCC 
AGC AGG AAG GAT CCC AAA TTC AGG GAG TGG CAC CAC TTC CTG GTG GTC AAC ATG AAG 
GGT AAT GAC ATT AGC AGT GGC ACT GTC CTC TCA GAT TAT GTG GGC TCC GGG CCT CCC 
AGT GGC ACA GGT CTC CAC CGC TAT GTC TGG CTG GTG TAC GAG CAG GAA CAG CCG CTG 
AGC TGC GAC GAG CCC ATT CTC AGC AAC AAG TCT GGA GAC AAT CGC GGC AAG TTC AAG 
GTG GAG ACC TTC CGC AAG AAG TAT AAC CTG GGA GCC CCG GTG GCG GGC ACG TGC 
TAC CAA GCC GAG TGG GAT GAC TAT GTG CCC AAG CTG TAC GAG CAG CTG TCA GGG AAG 
TAG 
C13; C133; C168 
 
Figure 3.4 - Coding sequences of C133S (A) and PEBP-1(B). After mutation of guanine 
nucleotide number 419 to a cytosine, sequencing of C133S was compared with the sequence of 
PEBP-1. Ser133: serine 133; C13: cysteine 13; C133: cysteine 133; C168: cysteine 168. 
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3.1.1.2.3. Construct C13S/C133S 
C13 and C133 were changed to Ser by mutating the guanine nucleotide of those amino 
acids to cytosine. Efficacy of this procedure was confirmed after sequencing PEBP-1 
C13S/C133S (C31S/C133S, Fig. 3.5A) and comparing it to the sequence of PEBP-1 WT 
(PEBP-1, Fig. 3.5B). We observed that both C13 and C133 had, in fact, been mutated 
to Ser and that no other mutations were introduced in the coding sequence of the gene. 
 
(A) C13S/C133S coding sequence 
ATG GCC GCC GAC ATC AGC CAG TGG GCC GGG CCC TTG TCC TTG CAG GAG GTG GAC 
GAG CCG CCC CAG CAC GCC CTG CGG GTC GAC TAC GCC GGG GTG ACG GTG GAC GAG 
CTG GGC AAA GTG CTA ACG CCC ACC CAG GTT ATG AAC AGG  CCC AGC AGC ATT TCA TGG 
GAC GGC CTT GAT CCT GGG AAA CTC TAC ACC CTG GTC CTC ACA GAC CCC GAT GCT CCC 
AGC AGG AAG GAT CCC AAA TTC AGG GAG  TGG CAC CAC TTC CTG GTG GTC AAC ATG AAG 
GGT AAT GAC ATT AGC AGT GGC ACT GTC CTC TCA GAT TAT GTG GGC TCC GGG CCT CCC 
AGT GGC ACA GGT CTC CAC CGC TAT GTC TGG CTG GTG TAC GAG CAG GAA CAG CCG CTG 
AGC TCC GAC GAG CCC ATT CTC AGC AAC AAG TCT GGA GAC AAT CGC GGC AAG TTC AAG 
GTG GAG ACC TTC CGC AAG AAG TAT AAC CTG GGA GCC CCG GTG GCG GGC ACG TGC 
TAC CAA GCC GAG TGG GAT GAC TAT GTG CCC AAG CTG TAC GAG CAG CTG TCA GGG AAG 
TAG 
Ser13; Ser133; C168 
 
(B) PEBP-1 coding sequence 
ATG GCC GCC GAC ATC AGC CAG TGG GCC GGG CCC TTG TGC TTG CAG GAG GTG GAC 
GAG CCG CCC CAG CAC GCC CTG CGG GTC GAC TAC GCC GGG GTG ACG GTG GAC GAG 
CTG GGC AAA GTG CTA ACG CCC ACC CAG GTT ATG AAC AGG CCC AGC AGC ATT TCA TGG 
GAC GGC CTT GAT CCT GGG AAA CTC TAC ACC CTG GTC CTC ACA GAC CCC GAT GCT CCC 
AGC AGG AAG GAT CCC AAA TTC AGG GAG TGG CAC CAC TTC CTG GTG GTC AAC ATG AAG 
GGT AAT GAC ATT AGC AGT GGC ACT GTC CTC TCA GAT TAT GTG GGC TCC GGG CCT CCC 
AGT GGC ACA GGT CTC CAC CGC TAT GTC TGG CTG GTG TAC GAG CAG GAA CAG CCG CTG 
AGC TGC GAC GAG CCC ATT CTC AGC AAC AAG TCT GGA GAC AAT CGC GGC AAG TTC AAG 
GTG GAG ACC TTC CGC AAG AAG TAT AAC CTG GGA GCC CCG GTG GCG GGC ACG TGC 
TAC CAA GCC GAG TGG GAT GAC TAT GTG CCC AAG CTG TAC GAG CAG CTG TCA GGG AAG 
TAG 
C13; C133; C168 
 
Figure 3.5 - Coding sequences of C13S/C133S (A) and PEBP-1 (B). After mutation of guanine 
nucleotides number 59 and 419 to cytosines, sequencing of C13S/C133S was compared with the 
sequence of PEBP-1. Ser13: serine 13; Ser133: serine 133; C13: cysteine 13; C133: cysteine 
133; C168: cysteine 168. 
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3.1.1.2.4. Construct C168S 
C168 was changed to Ser by mutating the guanine nucleotide of that aminoacid to a 
cytosine. Efficacy of this procedure was confirmed after sequencing PEBP-1 C168S 
(C168S, Fig. 3.6A) and comparing it to the sequence of PEBP-1 WT (PEBP-1, Fig. 3.6B). 
We observed that C168 had, in fact, been mutated to Ser and that no other mutations 
were introduced in the coding sequence of the gene. 
 
(A) C168S coding sequence 
ATG GCC GCC GAC ATC AGC CAG TGG GCC GGG CCC TTG TGC TTG CAG GAG GTG GAC 
GAG CCG CCC CAG CAC GCC CTG CGG GTC GAC TAC GCC GGG GTG ACG GTG GAC GAG 
CTG GGC AAA GTG CTA ACG CCC ACC CAG GTT ATG AAC AGG  CCC AGC AGC ATT TCA TGG 
GAC GGC CTT GAT CCT GGG AAA CTC TAC ACC CTG GTC CTC ACA GAC CCC GAT GCT CCC 
AGC AGG AAG GAT CCC AAA TTC AGG GAG  TGG CAC CAC TTC CTG GTG GTC AAC ATG AAG 
GGT AAT GAC ATT AGC AGT GGC ACT GTC CTC TCA GAT TAT GTG GGC TCC GGG CCT CCC 
AGT GGC ACA GGT CTC CAC CGC TAT GTC TGG CTG GTG TAC GAG CAG GAA CAG CCG CTG 
AGC TGC GAC GAG CCC ATT CTC AGC AAC AAG TCT GGA GAC AAT CGC GGC AAG TTC AAG 
GTG GAG ACC TTC CGC AAG AAG TAT AAC CTG GGA GCC CCG GTG GCG GGC ACG TCC 
TAC CAA GCC GAG TGG GAT GAC TAT GTG CCC AAG CTG TAC GAG CAG CTG TCA GGG AAG 
TAG 
C13; C133; Ser168 
 
(B) PEBP-1 coding sequence 
ATG GCC GCC GAC ATC AGC CAG TGG GCC GGG CCC TTG TGC TTG CAG GAG GTG GAC 
GAG CCG CCC CAG CAC GCC CTG CGG GTC GAC TAC GCC GGG GTG ACG GTG GAC GAG 
CTG GGC AAA GTG CTA ACG CCC ACC CAG GTT ATG AAC AGG CCC AGC AGC ATT TCA TGG 
GAC GGC CTT GAT CCT GGG AAA CTC TAC ACC CTG GTC CTC ACA GAC CCC GAT GCT CCC 
AGC AGG AAG GAT CCC AAA TTC AGG GAG TGG CAC CAC TTC CTG GTG GTC AAC ATG AAG 
GGT AAT GAC ATT AGC AGT GGC ACT GTC CTC TCA GAT TAT GTG GGC TCC GGG CCT CCC 
AGT GGC ACA GGT CTC CAC CGC TAT GTC TGG CTG GTG TAC GAG CAG GAA CAG CCG CTG 
AGC TGC GAC GAG CCC ATT CTC AGC AAC AAG TCT GGA GAC AAT CGC GGC AAG TTC AAG 
GTG GAG ACC TTC CGC AAG AAG TAT AAC CTG GGA GCC CCG GTG GCG GGC ACG TGC 
TAC CAA GCC GAG TGG GAT GAC TAT GTG CCC AAG CTG TAC GAG CAG CTG TCA GGG AAG 
TAG 
C13; C133; C168 
 
Figure 3.6 - Coding sequences of C168S (A) and PEBP-1 (B). After mutation of guanine 
nucleotide number 524 to a cytosine, sequencing of C168S was compared with the sequence of 
PEBP-1. Ser168: serine 168; C13: cysteine 13; C133: cysteine 133; C168: cysteine 168. 
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3.1.1.3. Overexpression of PEBP-1 in NSC 
Overexpression of normal and mutant PEBP-1 in NSC was assessed by 
immunocytochemistry and detected by fluorescence microscopy. The antibody used for 
detection of PEBP-1 was shown to detect PEBP-1 in the cytoplasm of NSC (Fig. 3.7). 
 
 
 
Figure 3.7 - PEBP-1 is present in the cytoplasm of NSC. Presence of PEBP-1 in SVZ-derived 
NSC was assessed by immunocytochemistry. Specificity of antibody binding was evaluated 
without anti-PEBP-1 antibody (A). Representative image of PEBP-1 in SVZ-derived NSC (B). 
PEBP-1, red; nuclei labeled with Hoechst 33342, blue. Scale bar: 40 µm.  
 
 
To assess the outcome of transfection, NSC were transfected with the constructs of 
normal (Fig. 3.8B) and mutant PEBP-1 (Fig. 3.8C-F), and overexpression was evaluated 
by immunocytochemistry. Signal was considered positive for overexpression when the 
signal of endogenous PEBP-1 was reduced to background levels by the strongly labeled 
transfected cells. We observed that transfection of NSC with the PEBP-1 constructs 
induced overexpression resulting in high levels of this protein (Fig. 3.8B-F). 
Overexpression of normal PEBP-1 was also assessed by Western blot, which confirmed 
the increase in PEBP-1 levels (Fig. 3.8A). 
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Figure 3.8 - Transfection of NSC with the different constructs induces PEBP-1 
overexpression. SVZ-derived NSC were transfected with PEBP-1 (A, B), C13S (C), C133S (D), 
C13S/C133S (E) and C168S (F) constructs. Overexpression of PEBP-1 was evaluated by 
Western blot using α-tubulin as a loading control (A) and by immunocytochemistry (B-F). PEBP-
1, red; nuclei labeled with Hoechst 33342, blue. Scale bar: 40 µm.  
 
3.1.1.4. S-nitrosylation of PEBP-1 mutants 
To assess if the observed S-nitrosylation of PEBP-1 was due to reaction of NO with 
PEBP-1 cysteines, we evaluated S-nitrosylation of this protein in the absence of each 
cysteine, by ascorbate-reducing biotin switch assay. NSC were transfected with normal 
and mutant PEBP-1 constructs and treated with 10 M NOC-18 for 10 min, the time point 
at which we previously observed highest S-nitrosylation levels of PEBP-1. We observed 
that treatment of transfected NSC with NOC-18 did not change the levels of S-
nitrosylation of PEBP-1 comparing with non-treated cells (Fig. 3.9). 
 
 
 
Figure 3.9 - Treatment of NSC with NOC-18 maintains S-nitrosylation of PEBP-1 after 
transfection with the different constructs. SVZ-derived NSC were transfected with PEBP-1, 
C13S, C133S, C13S/C133S and C168S constructs and treated with 10 M NOC-18 for 10 min. 
S-nitrosylation of PEBP-1 was evaluated by ascorbate-reducing biotin switch assay. 
Representative image of 3 independent experiments. SNO PEBP-1, S-nitrosylated protein. 
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Due to the lack of effect of treatment of NOC-18, we compared the potential to induce 
S-nitrosylation of proteins of CysNO, NOC-18 and another NO donor with a shorter half-
life (DEA/NO) using fluorescence switch assay. However, detection of S-nitrosylation 
(Fig. 3.10A, ascorbate) using this technique required higher amount of protein and was 
more difficult to achieve, when comparing with oxidation (Fig. 3.10A, DTT). Since S-
nitrosylation is an oxidative reaction, we compared the effect of the compounds in protein 
oxidation. NSC were treated with 100 M CysNO for 15 min, 10 M NOC-18 for 1 h, and 
100 M and 1 mM DEA/NO for 15 min. We observed that treatment with both NO donors 
did not change protein oxidation, comparing with control, and that CysNO induced 
oxidation of proteins (Fig. 3.10B).  
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Figure 3.10 - Treatment of NSC with CysNO, but not NOC-18 or DEA/NO, induces strong 
oxidation of proteins. SVZ-derived NSC were treated with 100 M CysNO for 15 min (A, B), 
100 M and 1 mM DEA/NO for 15 min, and 10 M NOC-18 for 1 h (B). Oxidation was assessed 
by DTT-reducing fluorescence switch (A, B) and S-nitrosylation was assessed by ascorbate-
reducing fluorescence switch (A). A negative control without addition of DTT and ascorbate was 
performed. Fluorescein, S-nitrosylated or oxidized protein; Coomassie Blue, total protein. 
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Having established that treatment with CysNO was the best option to be able to detect 
protein oxidation/S-nitrosylation, S-nitrosylation of PEBP-1 was assessed in transfected 
NSC treated with 100 M CysNO for 15 min. We observed that treatment of transfected 
NSC with CysNO induced S-nitrosylation of PEBP-1, regardless of cysteine mutation 
(Fig. 3.11). 
 
 
 
Figure 3.11 - Treatment of NSC with CysNO induces S-nitrosylation of PEBP-1 after 
transfection with the different constructs. SVZ-derived NSC were transfected with PEBP-1, 
C13S, C133S, C13S/C133S and C168S constructs and treated with 100 M CysNO for 15 min. 
S-nitrosylation of PEBP-1 was evaluated by ascorbate-reducing biotin switch assay. 
Representative image of 2-4 independent experiments. SNO PEBP-1, S-nitrosylated protein. 
 
3.1.1.5. PEBP-1 cysteine 133 is necessary for NO-dependent activation of ERK 
If NO-mediated S-nitrosylation of PEBP-1 affects neurogenesis stimulated by NO, the 
next step would be to investigate whether S-nitrosylation of PEBP-1 can affect the 
activation of the ERK/MAPK pathway, which was described to occur shortly after NO 
treatment in NSC (Carreira et al, 2010), in cells expressing either PEBP-1 or the various 
cysteine mutants. ERK phosphorylation was assessed by immunocytochemistry. To 
evaluate the optimal conditions for ERK phosphorylation induced by NO, NSC were 
treated with 10 M CysNO for 5 min and 10 M NOC-18 for 20 min. As a positive control 
NSC were treated with 20 ng/ml EGF for 20 min. Untreated cells were considered the 
control. We observed that treatment with CysNO (Fig. 3.12B) and NOC-18 (Fig. 3.12C) 
increased ERK phosphorylation comparing with control (Fig. 3.12A). The highest 
increase in P-ERK levels was achieved in cells treated with the positive control EGF (Fig. 
3.12D). 
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Figure 3.12 - Treatment of NSC with CysNO and NOC-18 increases ERK phosphorylation. 
SVZ-derived NSC were treated with 10 M CysNO for 5 min (B) and 10 M NOC-18 for 20 min 
(C). Cells without treatment (A) were considered the control, and cells treated with 20 ng/ml EGF 
for 20 min were used as a positive control (D). ERK phosphorylation was detected by 
immunocytochemistry. P-ERK, green; nuclei labeled with Hoechst 33342, blue. Scale bar: 40 µm.  
 
To assess the role of PEBP-1 S-nitrosylation in ERK phosphorylation caused by NO, 
NSC were transfected with normal and mutant PEBP-1 constructs and treated with 10 
M CysNO for 5 min (Fig. 3.13A). Cells treated with 20 ng/ml EGF were used as a 
positive control, and cells with no treatment were considered the control (Fig. 3.13A). 
Fluorescence of P-ERK was measured in PEBP-1-overexpressing cells (Fig. 3.13B, 
3.13C). Treatment of NSC transfected with PEBP-1 with CysNO significantly increased 
P-ERK levels (11.4  1.1%, p<0.05, Fig. 3.13B), comparing with control (7.4  1.3%). 
NSC transfected with C13S (10.6  0.9%) and C168S (10.1  1.2%) treated with CysNO 
showed a tendency to have increased P-ERK levels, comparing with control (C13S, 8.1 
 0.9%; C168S, 8.1  1.2%). Transfection of NSC with C133S (8.9  1.4%) and 
C13S/C133S (7.8  0.7%) did not increase P-ERK levels after treatment with CysNO, 
comparing with control (C133S, 7.6  0.4%; C13S/C133S, 7.4  1.3%). Treatment with 
EGF significantly increased P-ERK levels in transfected NSC, regardless of the 
construction (PEBP-1, 18.6  1.4% p<0.001; C13S, 16.6  2.1% p<0.01; C133S, 16.7  
1.7% p<0.001; C13S/C133S, 19.7  1.7% p<0.001; C168S, 18.9  1.5% p<0.001, Fig. 
3.13C), comparing with the respective controls. 
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Figure 3.13 - Transfection of NSC with C13S/C133S construct prevents the increase in ERK 
phosphorylation induced by CysNO. SVZ-derived NSC were transfected with PEBP-1, C13S, 
C133S, C13S/C133S and C168S constructs, and treated with 10 µM CysNO for 5 min.  Cells 
without treatment were considered the control, and cells treated with 20 ng/ml EGF for 20 min 
were used as a positive control. ERK phosphorylation and overexpression of PEBP-1 were 
detected by immunocytochemistry. Representative images are shown (A). PEBP-1, red; P-ERK, 
green; nuclei labeled with Hoechst 33342, blue. Scale bar: 40 µm. Data from 4-5 independent 
experiments are presented as means  SEM of arbitrary units of P-ERK fluorescence (B, C). Two-
tailed Student’s t-test, * p<0.05, ** p<0.01 and *** p<0.001 significantly different from control. 
 
 
3.1.1.6. PEBP-1 overexpression inhibits NSC proliferation 
To evaluate the effect of S-nitrosylation of PEBP-1 in cell proliferation, NSC were 
transfected with normal and mutant PEBP-1 constructs, treated with 10 M NOC-18 for 
1 h, and the incorporation of EdU was analyzed (3.14A). Cells with no treatment were 
considered the control. Treatment with NOC-18 significantly increased the number of 
EdU-positive cells in non-transfected cells, comparing with control, in PEBP-1 (control 
1.6  0.3%, NOC-18 5.3  1.1%, p<0.05), C13S (control 2.2  0.3%, NOC-18 5.1  0.2%, 
p<0.01), C133S (control 1.7  0.4%, NOC-18 4.7  0.7%, p<0.05) and C13S/C133S 
(control 2.3  0.3%, NOC-18 5.5  0.5%, p<0.05) transfection conditions (Fig. 3.14B). 
We also observed that non-treated transfected cells were EdU-negative, and that this 
effect was not prevented with treatment with NOC-18 (Fig. 3.14A). 
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Figure 3.14 - Overexpression of normal and mutant PEBP-1 inhibits proliferation of NSC, 
which is not prevented by treatment with NOC-18. SVZ-derived NSC were transfected with 
PEBP-1, C13S, C133S and C13S/C133S constructs, and treated with 10 µM NOC-18 for 1 h.  
Cells without treatment were considered the control. Proliferation was assessed by incorporation 
of EdU (10 µM, 1 h), analyzed by fluorescence microscopy. Representative images are shown 
(A). EdU, green; PEBP-1, red; nuclei labeled with Hoechst 33342, blue. Scale bar: 40 µm. Data 
from 2-3 independent experiments are presented as means  SEM of the number of positive cells 
for EdU of the total non-apoptotic cells (%) (B). Two-tailed Student’s t-test, * p<0.05 and ** p<0.01 
significantly different from control. 
 
3.1.2. S-nitrosylation of PEBP-1 in hippocampus after seizures 
3.1.2.1. PEBP-1 is S-nitrosylated by NO in the DG after seizures 
To study the role of PEBP-1 S-nitrosylation in post-injury neurogenesis, we used an 
excitotoxic lesion mouse model that is characterized by an increase in neurogenesis in 
the DG after induction of seizures with KA (Parent 2007). In this model, NO is essential 
for the increased neurogenic response observed as a reaction to seizures induced by 
KA (Carreira et al. 2010). WT mice were injected with KA (25 mg/kg, s.c.) or SAL (control) 
and sacrificed 1, 2, 3 and 5 days later for dissection of the DG. S-nitrosylation of PEBP-
1 was evaluated by ascorbate-reducing biotin switch assay (Fig. 3.15A). We observed 
that, 1 day after KA injection, S-nitrosylation of PEBP-1 significantly increased (173.9  
16.4%, p<0.01) comparing with control (SAL). S-nitrosylation of PEBP-1 was unchanged 
2 (86.3  11.8%), 3 (123.2  31.4%) and 5 days (63.2  10.8%) after seizure onset, 
comparing with control (SAL). 
To assess the role of NO in the increase of PEBP-1 S-nitrosylation 1 day after SE, iNOS 
KO- mice were injected with KA or SAL, sacrificed 1 day later and DG was dissected. 
PEBP-1 S-nitrosylation was evaluated by ascorbate-reducing biotin switch assay (Fig. 
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3.15B). We observed that S-nitrosylation of PEBP-1 significantly decreased 1 day after 
seizure onset  (58.3  8.9%, p<0.01) comparing with control (SAL). 
 
 
 
 
 
Figure 3.15 - PEBP-1 S-nitrosylation is transiently induced by NO after seizures, in the DG. 
Wild type (A) and iNOS KO (B) C57Bl6 mice were subcutaneously injected with a sterile solution 
of kainic acid (KA, 25 mg/kg) in 0.9% NaCl, achieving epileptic seizures. Control animals were 
injected the vehicle saline solution (SAL). The animals were sacrificed 1, 2, 3 and 5 days after 
the injection, and protein lysates of the DG were used to analyze S-nitrosylation of PEBP-1 by 
ascorbate-reducing biotin switch assay. Data from 5-6 animals are presented as means ± SEM 
and (% of control, SAL). Two-way ANOVA followed by Bonferroni’s post-hoc test (A) and 
Student’s t-test (B), ** p<0.01 significantly different from saline. SNO PEBP-1, S-nitrosylated 
protein; SAL, saline; KA, kainic acid; d, days. 
 
To investigate S-nitrosylation of PEBP-1 in the stem cells of the DG, cultured 
hippocampal stem cells were treated with different concentrations of CysNO (10, 50 and 
100 µM) for 15 min, and S-nitrosylation of PEBP-1 was analyzed by ascorbate-reducing 
biotin switch (Fig. 3.16). We observed that S-nitrosylation of PEBP-1 was unchanged 
after treatment with 10 M CysNO (98.4  5.4%), comparing with control. Treatment with 
50 M CysNO showed a tendency to increase S-nitrosylation of PEBP-1 (204.3  73.7%) 
and treatment with 100 M CysNO significantly increased PEBP-1 S-nitrosylation (339.9 
 100.0%, p<0.05), comparing with control. 
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Figure 3.16 - Treatment of hippocampal stem cells with CysNO induces PEBP-1 S-
nitrosylation in a dose-dependent manner. Hippocampal stem cells were treated with 10 µM, 
50 µM and 100 µM CysNO for 15 min. S-nitrosylation of PEBP-1 was assessed by ascorbate-
reducing biotin switch assay. Data from 4 independent experiments are presented as means ± 
SEM (% of control, 0, no treatment). One-Way ANOVA followed by Dunnett’s post-hoc test, * 
p<0.05 significantly different from control. SNO PEBP-1, S-nitrosylated protein. 
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3.2. S-nitrosylation targets of NO after brain injury 
3.2.1. hnRNP K, 14-3-3 and 14-3-3  are S-nitrosylated after KA-induced seizures 
Previous work by our group identified several proteins that are S-nitrosylated by NO in 
SVZ-derived NSC (Ana I. Santos, unpublished results). We aimed to assess if these 
proteins were S-nitrosylated in a model of hippocampal post-injury neurogenesis 
mediated by NO. To validate the new putative S-nitrosylation targets of NO, we used the 
same seizure model as described above for PEBP-1. Mice were injected with KA (25 
mg/kg) or SAL (control) and sacrificed 1, 2, 3 and 5 days later for dissection of the DG. 
S-nitrosylation of proteins was evaluated by ascorbate-reducing biotin switch assay.  
Of the analyzed proteins, we observed S-nitrosylation of hnRNP K, 14-3-3 and 14-3-3 , 
but not of PCNA or EF-1 (Fig. 3.17A). hnRNP K S-nitrosylation significantly increased 
2 days after seizure onset (195.5  45.0%, p<0.05, Fig. 3.17B), comparing with control. 
1 day (139.8  30.7%), 3 days (94.4  29.0%) and 5 days (86.0  16.9%) after KA 
treatment, S-nitrosylation of hnRNP K was similar to control. We first evaluated S-
nitrosylation of all 14-3-3 proteins isoforms, which significantly increased 1 day after KA 
treatment (149.9  34.8%, p<0.05, Fig. 3.17C), and was similar to control 2 days (112.2 
 22.9%), 3 days (88.5  14.3%) and 5 days (71.9  15.4%) after seizure onset. S-
nitrosylation of 14-3-3 , the most interesting isoform regarding neurogenesis, showed a 
tendency to increase 1 day (147.8  37.2%, Fig. 3.17D) and 2 days (141.6  28.4%) after 
seizure onset, and was maintained 3 days (75.7  18.4%) and 5 days (69.7  18.5%) 
after seizure onset, comparing with control. 
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Figure 3.17 - Induction of epileptic seizures in mice leads to S-nitrosylation of proteins in 
the DG. Wild type C57Bl6 mice were subcutaneously injected with a sterile solution of kainic acid 
(KA, 25 mg/kg) in 0.9% NaCl, achieving epileptic seizures. Control animals were injected the 
vehicle saline solution (SAL). The animals were sacrificed 1, 2, 3 and 5 days after the injection, 
and protein lysates of the DG were used to analyze S-nitrosylation of hnRNP K, PCNA, 14-3-3 
proteins and EF-1 by ascorbate-reducing biotin switch assay (A). Data from at least 3 animals 
are presented as means ± SEM and (% of control, SAL) (B-D). Two-way ANOVA followed by 
Bonferroni’s post-hoc test, * p<0.05 significantly different from saline. SNO protein, S-nitrosylated 
protein; SAL, saline; KA, kainic acid; d, days. 
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3.2.2. hnRNP K, PCNA, 14-3-3  and EF-1 are S-nitrosylated in hippocampal stem 
cells 
To investigate S-nitrosylation of the identified proteins in stem cells of the DG, we treated 
hippocampal stem cells with different concentrations of CysNO (10, 50 and 100 µM) for 
15 min and analyzed S-nitrosylation of hnRNP K, PCNA, 14-3-3  and EF-1 by 
ascorbate-reducing biotin switch (Fig. 3.18A). We observed that hnRNP K S-nitrosylation 
showed a tendency to increase after treatment with 10 (243.2  77.2%, Fig. 3.18B) and 
50 µM CysNO (294.0  97.1%), and significantly increased after treatment with 100 µM 
CysNO (487.9  112.65%, p<0.01), comparing with control. Treatment with 100 M 
CysNO significantly increased PCNA S-nitrosylation (260.7  85.9%, p<0.05, Fig. 
3.18C), while with treatment with 10 (134.7  25.8%) and 50 M CysNO (156.2  31.8%) 
S-nitrosylation was similar to control. S-nitrosylation of 14-3-3  showed a tendency to 
increase after treatment with 10 (241.5  44.1%, Fig. 3.18D) and 50 M CysNO (256.7 
 21.0%), and significantly increased after treatment with 100 M CysNO (682.1  
209.3%, p<0.05), comparing with control. S-nitrosylation of EF-1 was maintained after 
treatment with 10 M CysNO (186.3  32.5%, Fig. 3.18E), and significantly increased 
after treatment with 50 (256.1  34.6%, p<0.01) and 100 M CysNO (234.2  34.4%, 
p<0.05), comparing with control.  
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Figure 3.18 - Treatment of hippocampal stem cells with CysNO induces S-nitrosylation of 
proteins in a dose-dependent manner. Hippocampal stem cells were treated with 10 µM, 50 
µM and 100 µM CysNO for 15 min. S-nitrosylation of hnRNP K, PCNA, 14-3-3  and EF-1 was 
assessed by ascorbate-reducing biotin switch assay (A). Data from at least 3 independent 
experiments are presented as means ± SEM (% of control, 0, no treatment) (B-E). One-Way 
ANOVA followed by Dunnett’s post-hoc test, * p<0.05 and ** p<0.01 significantly different from 
control. SNO PEBP-1, S-nitrosylated protein. 
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NO is a signaling molecule with several functions in the organism. Through S-
nitrosylation, NO can modify the function of proteins relevant for many processes. As an 
important regulator of adult endogenous neurogenesis, NO is able to increase NSC 
proliferation after brain injury (Carreira et al. 2010). However, this repair process is not 
efficient (Carreira et al. 2015). The proliferative effect of NO is mediated by activation of 
the ERK/MAPK pathway, bypassing the EGFR, and directly activating p21Ras by S-
nitrosylation (Carreira et al. 2010, Carreira et al. 2013, Santos et al. 2017, Carreira et al. 
2012). The identification of proteins that could contribute to improve post-injury 
neurogenesis outcome is therefore of particular importance. 
Our group identified recently several proteins as new targets of S-nitrosylation by NO 
(Ana I. Santos, unpublished results). PEBP-1, one of the identified targets, is an 
important regulator of the ERK/MAPK pathway, being essential in the regulation of cell 
proliferation and differentiation. The presence of this protein in rat hippocampal stem 
cells is associated with more differentiation towards a neuronal lineage (Sagisaka et al. 
2010), making it a very interesting target to study regarding neurogenesis. It is 
particularly important to understand the regulation of PEBP-1 activity, in order to be 
possible to modulate it to increase neurogenesis. With this work, we aimed to investigate 
the role of S-nitrosylation of the new targets in neurogenesis, and study in more detail 
the role of S-nitrosylation of PEBP-1 in NSC proliferation. Using normal PEBP-1 and 
mutant forms of PEBP-1 insensitive to NO, we evaluated S-nitrosylation of PEBP-1 in 
NSC and its effect on ERK/MAPK signaling and proliferation. Moreover, we assessed 
the biological relevance of S-nitrosylation of PEBP-1 in a model of increased post-injury 
neurogenesis and in hippocampal stem cells. S-nitrosylation of other identified proteins 
that are related to ERK/MAPK pathway was also evaluated in the model of post-injury 
neurogenesis and in hippocampal stem cells. 
Our results show that PEBP-1 is oxidized by CysNO, which is in accordance with our 
first results obtained upon the identification of oxidized proteins by NO, using a different 
labeling technique (Ana I. Santos, unpublished results). Moreover, we show that CysNO 
specifically induces S-nitrosylation of PEBP-1, and that this reaction is fast (1-2 min). 
Given the fact that CysNO is a S-nitrosothiol compound, it makes sense that the transfer 
of the S-nitrosothiol group from CysNO to PEBP-1 would be a quick process. Since our 
main interest was to study the S-nitrosylation of PEBP-1 under proliferative conditions, 
we used a NO donor, at a concentration previously established as being proliferative, 
and different exposure times (Carreira et al. 2010, Carreira et al. 2013, Santos et al. 
2017). Our results show that S-nitrosylation of PEBP-1 increases after exposure to NO 
during 10 min. The detection of S-nitrosylation of PEBP-1 by NO after treatment with 10 
M NOC-18 was difficult to achieve, and the levels of S-nitrosylation induced by 100 M 
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CysNO were much higher than those induced by NOC-18. In transfected cells, we were 
not able to detect an increase in S-nitrosylation of PEBP-1 after treatment with NOC-18. 
So, we evaluated which could be a better compound to induce S-nitrosylation, using a 
fluorescence switch assay. This technique allows the labeling of oxidized or S-
nitrosylated proteins present in a protein lysate, depending on the reducing agent used. 
Detection of S-nitrosylation by fluorescence switch was difficult, due to the high 
specificity and low sensitivity of the assay. Since S-nitrosylation is an oxidation process, 
a compound that does not induce oxidation of proteins will also not induce S-
nitrosylation. Therefore, we evaluated oxidation instead of S-nitrosylation. We used the 
S-nitrosothiol CysNO at the concentration that had previously induced S-nitrosylation of 
PEBP-1, and NOC-18 at the known proliferative concentration, but longer exposure time. 
Additionally, since S-nitrosylation is a fast reversible reaction, we used DEA/NO, a NO 
donor with a short half-life, at high concentrations. We were only able to detect protein 
oxidation induced by CysNO. The different response to treatment to CysNO and NO 
donors can occur because CysNO and NO released from NO donors are metabolized 
differently (Hickok et al. 2012). In order to produce nitrosothiols and induce 
transnitrosylation, CysNO does not need to release NO, while NO released from NO 
donors requires an oxidation reaction. Moreover, CysNO generates higher amounts of 
nitrosothiols than NO, which could differently affect the biological effect of both 
compounds.  
Therefore, we performed the experiments of S-nitrosylation detection and cell signaling 
analysis using CysNO. Cell proliferation analysis was done using the NO donor, to be 
more representative of the biological response of NO. Treatment of transfected cells with 
CysNO induced PEBP-1 S-nitrosylation, regardless of the mutation present in the 
protein. This can be explained by the low transfection efficiency of the constructs in NSC. 
The observed signal may be from the endogenous PEBP-1 present, which has all 3 
cysteines available to react with NO. NSC are very difficult cells to transfect so, since we 
could easily detect the presence of endogenous PEBP-1, we can assume that its levels 
were high enough to interfere with the exogenous modified PEBP-1. One way to analyze 
S-nitrosylation only in PEBP-1-overexpressing cells could be to add a tag to our 
constructs. That would allow us to separate transfected cells from non-transfected cells 
by immunoprecipitation and evaluate S-nitrosylation only in that fraction of protein. 
Alternatively, this experiment could be done using viral vectors or nucleofection, which 
can be more efficient than cationic lipid mediated transfections (Rappa et al. 2004, 
Cesnulevicius et al. 2006).  
Since cell transfection efficiency was not enough to allow the detection of substantial 
differences by Western blot, immunocytochemistry was used for cell signaling and 
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proliferation experiments, as we were able to analyze only the transfected cells. 
Treatment of NSC with 10 M CysNO for 5 min increases P-ERK levels detected by 
Western Blot (Ana I Santos, unpublished results), so we tested if we could detect this 
effect by immunocytochemistry. CysNO and NOC-18 increased P-ERK levels of NSC. 
We used EGF, the EGFR agonist and an activator of the ERK/MAPK pathway as the 
positive control in the experiments of ERK phosphorylation, since its effect in activation 
of this pathway should be independent of the effect of NO. That way we could assure 
that possible differences in ERK phosphorylation between mutant forms of PEBP-1 were 
not due to a secondary effect caused by the mutations that affect protein function in such 
a way that it affects by itself the signaling pathway. Treatment with EGF induced ERK 
phosphorylation in PEBP-1-overexpressing NSC regardless of cysteine mutation, which 
shows that PEBP-1 mutants are functional and respond to EGF stimulation as normal 
PEBP-1. In NSC overexpressing normal PEBP-1, P-ERK levels were significantly 
increased by treatment with CysNO. However, in NSC transfected with C13S/C133S 
construct this effect was abolished, and also at a lower extent in NSC transfected with 
C133S. This may indicate that C133S is important for S-nitrosylation of PEBP-1 and that 
this reaction lowers its inhibitory effect in the ERK/MAPK pathway activation. PEBP-1 
binds to and inhibits c-Raf (Yeung et al. 1999) so, in order to allow ERK/MAPK activation 
and thus cell proliferation, its inhibitory effect on c-Raf must be released. The fact that 
prevention of ERK phosphorylation is more evident in the double mutant indicates that 
both C13 and C133 may be potential sites for S-nitrosylation of NO, but with C133 being 
the most important and preferential site for reacting with NO. In the absence of C133, 
C13 S-nitrosylation may be able to compensate at some extent, while in the opposite 
scenario C133 S-nitrosylation appears to be enough to increase ERK phosphorylation. 
In hippocampal stem cells, we observed S-nitrosylation of PEBP-1 induced by treatment 
with CysNO, dependent on its concentration. C13 is only present in mouse PEBP-1, 
being replaced by a serine in human and rat forms of PEBP-1. So, it makes sense that 
C133 can be more relevant than C13, with its biological role being present across 
different species. 
Regarding cell proliferation, overexpression of all forms of PEBP-1 inhibited proliferation 
of NSC, and that was not prevented with treatment with the proliferative concentration of 
NOC-18. P-ERK levels could be increased by CysNO, but treatment with NOC-18 was 
not able to induce proliferation of cells overexpressing PEBP-1. It is possible that the 
strong inhibitory effect caused by overexpression of PEBP-1 prevented the activation of 
ERK/MAPK pathway by NO to a threshold that could result in cell proliferation. 
Alternatively, NSC could have turned towards a more differentiated state upon 
overexpression of PEBP-1. Overexpression of PEBP-1 in neuroblastoma cells has been 
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shown to be able to promote neuronal differentiation, even in the absence of factors that 
induce differentiation of these cells (Hellmann et al. 2010). Differentiation is usually 
irreversible so, even in the presence of a proliferative agent, proliferation would not 
occur, regardless of the increase of P-ERK levels. One mechanism by which PEBP-1 is 
regulated is phosphorylation. PEBP-1 binds to c-Raf (Yeung et al. 2000) and, after being 
phosphorylated by PKC at Ser153 (Corbit et al. 2003), it binds to GRK2 (Lorenz et al. 
2003), allowing the activation of ERK/MAPK pathway. So, besides S-nitrosylation, 
PEBP-1 may need to be also phosphorylated in order to stop its inhibitory effect and 
allow cell proliferation to occur, although this was not addressed in this work. A three-
state allosteric model for regulation of PEBP-1 has been proposed (Skinner & Rosner 
2014). This model states that there is an intermediary state of PEBP-1 with which PKC 
interacts, rather than directly interacting with PEBP-1 bound to c-Raf. This is based on 
the fact that Ser153 is in a stable helix and to interact with a kinase it was expected to 
be part of an unfolded helix. Moreover, the authors hypothesize that the stability of this 
intermediary state of PEBP-1 is important for PEBP-1 regulation and that it could be 
affected by PTM. S-nitrosylation could be a mechanism by which this regulation of PEBP-
1 occurs, facilitating phosphorylation by PKC. 
The biological relevance of S-nitrosylation of PEBP-1 was evaluated using a mouse 
model of excitotoxic brain lesion that has increased proliferation in the DG following 
seizures (Parent 2007). PEBP-1 was S-nitrosylated 1 day after epileptic seizures. Given 
that in mice lacking iNOS there was no induction of S-nitrosylation of PEBP-1 at this time 
point, we can assume that NO from inflammatory origin (produced by iNOS in microglia) 
is responsible for PEBP-1 S-nitrosylation. The reaction of S-nitrosylation is reversible, 
and the NO-dependent proliferation in this model occurs 3-5 days after seizures (Carreira 
et al. 2015). If S-nitrosylation of PEBP-1 is important for interaction of PKC with this 
protein, this could explain how PEBP-1 releases its inhibitory function in the ERK/MAPK 
pathway and allows the increase in proliferation, which is observed later than PEBP-1 S-
nitrosylation. p21Ras, which is upstream of c-Raf, is S-nitrosylated 2 days after seizures 
in this model (Santos et al. 2017). So, upon being produced by iNOS due to the 
inflammation after KA-induced excitotoxicity, NO could react preferentially with C133 of 
PEBP-1, thereby facilitating PEBP-1 phosphorylation by PKC and binding to GRK2. 
Without PEBP-1 bound to c-Raf, S-nitrosylation of p21Ras could initiate the signaling 
cascade of ERK/MAPK and ultimately induce cell proliferation. 
To validate other S-nitrosylation targets we have previously identified in our group, we 
used the same mouse model of excitotoxic brain lesion described above. Transient S-
nitrosylation of hnRNP K, 14-3-3 and 14-3-3  was detected in this model. S-nitrosylation 
was present 1 day (14-3-3 and 14-3-3 ) or 2 days (hnRNP K) after the induction of 
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epileptic seizures. This occurs before the onset of proliferation of NSC in this model, 
which is observed 3 days after seizures and is dependent on NO released from iNOS 
(Carreira et al. 2015). Therefore, it is possible that, through regulation by NO from 
inflammatory origin, these proteins can contribute for the process of neurogenesis in this 
model, especially in proliferation. The fact that S-nitrosylation was observed at different 
times after seizures may be related to the different functions of these proteins. 14-3-3 
proteins seem to have an important role in excitotoxicity. In rat hippocampus, 4 h 
following KA-induced excitotoxicity, the levels of total 14-3-3 are reduced (Schindler et 
al. 2004). This decrease is isoform-selective and dependent on localization, with 14-3-3 
 and 14-3-3  levels being decreased in microsome-enriched fractions (Schindler et al. 
2006). A reduction in 14-3-3 protein levels has also been found in rat frontal cortex 24 h 
after KA treatment, with 14-3-3 , 14-3-3 , 14-3-3  and 14-3-3  levels being decreased. 
This effect is accompanied by an increase in ERK phosphorylation levels (Smani et al. 
2017), which is necessary for NSC proliferation. The decrease in 14-3-3 isoforms levels 
in certain cellular compartments after KA-induced excitotoxicity may be due to 
degradation by proteolysis (Henshall et al. 2002). However, it is probable that in others, 
such as the cytoplasm, regulation of 14-3-3 isoforms may occur through PTM, namely 
S-nitrosylation. As discussed above, PEBP-1 is S-nitrosylated 1 day after seizure onset 
in this mouse model. Both 14-3-3 proteins and PEBP-1 regulate the ERK/MAPK pathway 
and are rapidly S-nitrosylated following seizures. In a previous work, our group observed 
that p21Ras is S-nitrosylated 2 days after seizures (Santos et al. 2017), which suggests 
that, before acting directly on components of the ERK/MAPK pathway, NO reacts with 
regulators of this signaling pathway.  
hnRNP K is a substrate of ERK1/2, being accumulated in the cytoplasm upon 
phosphorylation by this kinase (Habelhah et al. 2001). Thus, it is not surprising that it is 
S-nitrosylated in a later time point than regulators of the ERK/MAPK pathway. In 
summary, it is possible that NO first S-nitrosylates PEBP-1 and 14-3-3 proteins, releasing 
the inhibitory effect of PEBP-1 and promoting the activating effect of 14-3-3 in c-Raf, 
followed by S-nitrosylation of members of the ERK/MAPK pathway (namely p21Ras) and 
of downstream proteins, such as hnRNP K (Fig. 4.1).  
Although S-nitrosylation of PCNA and EF-1 was not detected in this seizure model, their 
regulation by S-nitrosylation in other systems is not excluded. To evaluate S-nitrosylation 
of the identified targets in DG stem cells, we treated hippocampal stem cells with different 
concentrations of CysNO. S-nitrosylation of all the identified proteins was detected in a 
dose-dependent manner, with higher levels as the concentration of CysNO increased. 
The range of CysNO concentrations used in this study included positive and negative 
effects on cell proliferation. Treatment with the lowest concentrations of CysNO (10 and 
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50 M) for 1 h enhances the proliferation of SVZ-derived NSC, while treatment with the 
highest concentration of CysNO (100 M) inhibits this process (Ana I. Santos and Inês 
Araújo, data not shown). Interestingly, the proteins that were S-nitrosylated in the in vivo 
model showed a tendency to be S-nitrosylated by CysNO at the proliferative 
concentrations. Moreover, the proteins whose S-nitrosylation was not detectable in the 
in vivo model showed lower levels of S-nitrosylation, even at the highest CysNO 
concentration used, despite being S-nitrosylated by CysNO in SVZ-derived NSC (Ana I. 
Santos, Ana S. Lourenço and Inês Araújo, submitted). This further indicates a possible 
physiological relevance of the identified proteins for hippocampal neurogenesis.  
 
 
 
Figure 4.1 - Proposed model for S-nitrosylation of proteins by NO during post-injury 
neurogenesis. NO S-nitrosylates cysteine 133 of PEBP-1, facilitating phosphorylation of serine 
153 by PKC and releasing the inhibitory effect of PEBP-1 in c-Raf, and also S-nitrosylates 14-3-
3 , promoting the activating effect of 14-3-3  in c-Raf. This is followed by S-nitrosylation of 
members of the ERK/MAPK pathway, such as p21Ras, and of downstream proteins, such as 
hnRNP K, allowing cell proliferation. 
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The discovery of neural stem cells and replacement of lost neurons in the adult brain of 
mammals allowed the possibility for repair of damage after a brain lesion by regenerative 
medicine. The potential of endogenous neurogenesis for therapeutic use has been 
subject of investigation in the last years. NO has emerged as a regulator of 
neurogenesis, particularly in cell proliferation. A hallmark of inflammation is the activation 
of iNOS and release of high amounts of NO. By reacting with thiol groups of cysteine 
residues, NO regulates targets of S-nitrosylation relevant in post-injury hippocampal 
neurogenesis.  
We studied in more detail PEBP-1, one of the promising targets known to be involved in 
regulation of cell proliferation. S-nitrosylation of C133 seems to the function of several 
proteins by S-nitrosylation, resulting in their activation or inhibition. The identification and 
validation of S-nitrosylation targets of NO that could improve neurogenesis in conditions 
of brain lesion seems a crucial step for obtaining regenerative therapies through 
modulation of protein function. Our goal was to validate new be necessary for activation 
of the ERK/MAPK pathway and may be a mechanism by which it could function as a way 
of releasing the inhibitory effect of PEBP-1, probably facilitating its phosphorylation by 
PKC.  
Moreover, our work allowed the validation of S-nitrosylation of 14-3-3, 14-3-3 , hnRNP 
K and PEBP-1 in conditions of brain lesion. Overall, some of the studied proteins were 
shown to be S-nitrosylated following epileptic seizures, according to their cellular 
functions: first the regulators of ERK/MAPK pathway, then a downstream protein. This 
effect was observed before the onset of proliferation of NSC, which suggests that these 
proteins could have biological importance for the enhancement of hippocampal 
neurogenesis following brain lesion. The roles of the new identified targets of NO in 
neurogenesis deserve further investigation. Using mutant proteins with cysteines 
replaced with other aminoacids, or by direct genome editing with CRISPR-Cas9, the 
functions of these S-nitrosylation targets can be investigated on several processes, 
including proliferation of NSC. It would be interesting to evaluate S-nitrosylation of PEBP-
1 using mutant animals after genome editing of PEBP-1 cysteines, in both WT and iNOS 
KO mice, allowing the identification of the preferential S-nitrosylation sites of PEBP-1 in 
a context of brain lesion. Moreover, the study of the role of S-nitrosylation of PEBP-1 in 
the ability of PKC to phosphorylate this protein would also be of interest.  
More studies can now be developed in order to further understand the role of S-
nitrosylation of these proteins in conditions of neuroinflammation, to advance the 
knowledge about the role of NO in neurogenesis and its potential application to increase 
proliferation of NSC and enhance neuronal replacement.  
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